Humoral antibody response in the neonatal foal by Juelsgaard, Stephen Glen
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
1-1-1975
Humoral antibody response in the neonatal foal
Stephen Glen Juelsgaard
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital
Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital
Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Juelsgaard, Stephen Glen, "Humoral antibody response in the neonatal foal" (1975). Retrospective Theses and Dissertations. 18439.
https://lib.dr.iastate.edu/rtd/18439
Humoral antibody response in the neonatal foal 
by 
Stephen Glen Juelsgaard 
A Thesis Submitted to the 
·Graduate Faculty in Par'tial Fulfillment of 
The Requirements for the Degree of 
Department: 
· Major: 
MASTER OF SCIENCE 
Veterinary Clinical Sciences 
veterinary Clinical Sciences 
(Reproductive Diseases) 
Signatures have been redacted for privacy 
Iowa State University 
Aines, Iowa 
1975 
J 
ii 
zsa 
/ '/75' 
J"13 TABLE OF CONTENTS 
<!, ' :z...-
INTRODUCTION 
Page 
1 
LITERATURE REVIEW 3 
Factors Influencing the Immune Response 3 
Antibody Production in Neonates -6 
Calves 6 
Pigs 8 
Lambs 11 
Pups 12 
Rabbits 13 
Rats 16 
Maternal Antibody and the Immune Response 17 
Neonatal Immunity in the Foal 24 
EXPERIMENTAL PROCEDURE 33 
Animals 33 
Antigens 36 
Brucella - BSA 36 
Tetanus toxoid-killed equine encephalo-
myeli tis virus 37 
Immunization 
Serological Testing 
RESULTS 
Transfer of Maternal Antibody 
Response to Immunization 
Effect of colostrum deprivation 
Effect of age 
Effect of maternal antibody 
Persistence of Maternal Antibody 
DISCUSSION 
37 
43 
50 
50 
56 
56 
94 
113 
129 
145 
I 
~ 
SUMMARY 
BIBLIOGRAPHY 
ACKNOWLEDGMENTS 
iii 
Page 
173 
175 
190 
J 
1 
INTRODUCTION 
Immunology of the newborn and young animal has been a 
subject of considerable interest in the last two decades and 
is now being complemented by studies in the fetal animal which 
are receiving' similar attention. A large volume of information 
has accumulated concerning the development of immune functions 
in several animal species (130, 136). This'knowledge has led 
to a better understanding of the mechanisms involved in immune 
system responses to antigenic stimulation in all ages of 
animals and has also allowed the utilization of these immune 
mechanisms to provide protection to the newborn animal during 
this critical stage of its life. 
There are, however, several animal species in which there 
has been only a minimal amount of study done. Extrapolations 
from work in other species serve as a reference in these 
animals. In many cases such generalizations may be extreme+y 
useful, but there are both gross and subtle differences in 
immunologic functions among different species. These differ-
ences have been noted, as well, in studies on neonatal animals, 
and point to the need for more information in each particular 
species. 
The Equidae has been largely forgotten in immunologic 
studies, but this has not quelled the need for such work. 
With the resurgence of interest in the equine species, a desire 
for practical equine immunologic knowledge has surfaced. 
2 
This investigation, therefore, was conducted .to study the 
, humoral antibody response in the neonatal foal to various types 
of antigens. Studies were directed at determining the relation-
ship of responses to age, to the ingestion or deprivation of 
colostrum in early life and to the presence or absense of 
maternal antibody. Also investigated were the transfer of 
maternal antibody to the foal and its subsequent elimination. 
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LITERATURE REVIEW 
Factors Influencing the Immune Response 
Many factors can affect the humeral antibody response 
including the antigen used, the methods of introducing the 
antigen to the animal and the animal's capacity to respond to 
the ·antigen. This review will deal with only a few such 
factors that were examined in the course of the experimentation, 
i.e., the effects of antigenicity, species and age of the 
animal, the presence or absence of detectable, pre-existing, 
circulating antibody and the effect of prior sensitization. 
Antigenicity or the peculiar ability of a particular 
material to stimulate the body's immune system can greatly 
affect the response. Some important factors that can cause 
antigens to vary widely in this capacity include size, 
configuration, electrical charge, foreignness, degradability, 
and composition (40). In general, particulate antigens such 
as viruses and bacteria are more antigenic than soluble 
substances such as purified tetanus toxoid or human serum 
albumin (49). The antigenicity of such soluble materials can 
be enhanced by combining them with an adjuvant. 
Adjuvants are materials that convert an apparently non-
antigenic substance into.an effective antigen or that are used 
to increase levels of circulating antibody (156). In the 
latter case the use of an intramuscular injection of adjuvanted 
material requires more time for antibody formation and the 
antibody levels increase more slowly than with intravenous 
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injection of nonadjuvanted material, but higher levels are 
attained and they decline more slowly (49). Adjuvant action 
is particularly valuable with highly soluble antigens of low 
molecular weight (49). 
Some common adjuvants include Freund's complete (FCA) 
and incomplete adjuvant (FIA), alum and other aluminum salts 
including aluminum hydroxide, bentonite, and bacterial endo-
toxins (156). Freund's incomplete adjuvant contains a mixture 
of mineral oil and a detergent; killed mycobacteria are added 
to produce FCA (49). An aqueous antigen can be emulsified in 
these preparations. Although it is the most effective adjuvant, 
FCA produces local necrotic granulomas at the inj.ection site, 
and thus its use is limited to experimental purposes (54). 
Aluminum hydroxide has gained wide acceptance in commercial 
antigenic preparations such as adjuvanted tetanus toxoid 
products (54). Bentonite (silica) has demonstrated an adjuvant 
effect in rats and rabbits (96) and in guinea pigs (158) where 
it was as effective as FIA in stimulating antibody production. 
Other adjuvants have been used less commonly and primarily for 
experimental purposes (49, 156). 
The species of animal involved is a weighing factor in 
the humoral antibody response. Bacteria and viruses which are 
immunogenic for one animal species may produce little effect 
in another species. Keyhole limpet hemocyanin is a powerful 
antigen in rabbits, but a poor one in rats (29). Rabbits are 
excellent antibody producers to diphtheria toxoid while guinea 
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pigs are poor producers {145). Species differences can be 
due to a number of factors including foreignness of antigen 
for the species, differences in the localization, processing 
and metabolism of an introduced antigen and differences in 
the biological activities of antibodies produced to the antigen. 
Age is another source of influence on the humoral anti-
body response. There are many reports of immunologic unrespon-
siveness or hyporesponsiveness in newborn and very young 
animals of several species (130, 136) followed by a gradual 
development of productive capacities to those observed in 
adult animals. Reports indicate that some newborn or very 
young animals can respond well to certain antigens, perhaps 
even as well as an adult (20, 72). 
The presence or absense or pre-existing specific anti-
body appears to be involved in the regulation of humoral anti-
body production (43, 148). Specific passive antibodies 
present in sufficient levels are capable of inhibiting a 
primary response. This is true where antibody is already 
present ·before stimulation as well as when antibody is 
administered at the time of or within the first several days 
after inoculation {145). Less frequently, specific antibodies 
may block sensitization for a secondary response (146); the 
secondary response can also be suppressed to some degree (85, 
145). It has been shown that in some cases small amounts of 
specific antibody,injected with the antigen enhance a primary 
response (142, 154). 
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A final factor is the effect of prior sensitization on 
the humoral antibody response. Some doses of antigen are 
insufficient to stimulate detectable antibody formation but 
can prime animals for a secondary response upon subsequent 
contact with the antigen (115). Although it may appear 
serologically that .there was a lack of stimulation by the 
first dose, there is a rapid increase in antibody titer to 
levels typical of a secondary response with a second adminis-
tration. This may·be the resu1t of the production of predom-
inantly memory cells and few or no antibody-producing cells by 
a small antigen dose (16). 
Antibody Production in Neonates 
Calves 
Mitchell and Moore (84) studied the response of cattle 
to live Brucella abortus Sl9. In their study they inoculated 
a group of calves with no detectable anti-Brucella agglutinins 
and found that with increasing age during the first 200 days. 
of life, there was an increasing responsive ability although 
positive responses were noted in some animals inoculated as 
early as 10 days of age. 
In an attempt to determine the effect of colostrum 
deprivation on the neonatal immune response, Roberts et al. 
(106) administered heat~killed Salmonella dublin vaccine to 
colostrum-deprived and colostrum-fed calves at various intervals 
after birth. Calves in both groups responded from as early 
7 
as 2 days of age with the production of detectable antibody 
6 to 15 days post-inoculation. No difference was noted 
between the 2 treatment groups. 
Results somewhat contradictory to those of Roberts were 
obtained by Kerr (67). Heat-killed Salmonella dublin injected 
into calves lacking antibody to this antigen gave no.detectable 
response to inoculations at 7 and 14 days of age. A 3rd 
injection at 4 months gave a good response. Seven-day-old 
calves immunized with live Brucella abortus 819 (2 x 1010 ceils) 
had no detectable response. Inoculation of one animal with 
alcohol-precipitated B. abortus Sl9 at 3, 10, 15, and 30 days 
of age produced an agglutinating titer of 1:40 at 42 days. 
A 2nd inoculation at 4 months of age produced a rapid 
response in all animals. 
Henning (50) immunized one-week-old calves having no 
detectable "O" or "H" antibodies to Salmonella dublin with 
killed .§_. dublin in aluminum hydroxide. Most calves produced 
"H" agglutinins by 7 days post-inoculation, and a 2nd dose at 
30 days resulted in a marked response. No "O" agglutinins 
were produced following the first inoculation, while only 30-
40 percent of the calves responded at 30 days and usually with 
low levels. 
Calves inoculated before 22 days of age failed to respond 
to freeze-dried Trichomonas foetus bodies (68). Only weak 
primary responses were noted in animals inoculated during the 
second month of life, and responses increased with age to an 
adult-equivalent response at 5 months. 
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Smith and Ingram (128) used killed Salmonella pullorum, 
killed Klebsiella pneumoniae (polysaccharide antigen) and 
human serum albumin (HSA) in colostrum-deprived (CD) and 
colostrum-fed (CF) calves at one to 2 days, one and 2 weeks, 
and one and 2 months of age. The first group to respond to 
S. pullorum were those inoculated at 2 weeks, while the first 
response to the polysaccharide antigen was noted in the one-
month-old group. No differences in onset or responsiveness 
were noted between CD and CF groups. Human serum albumin 
given intravenously or intramuscularly failed to produce 
detectable antibodies in 3 to 6 month old calves. When 
mixed with Freund's incomplete adjuvant, HSA produced responses 
in one week old calves, and the CD calves seemed to respond 
better than CF calves. 
The response to a standard dose of attenuated Mycoplasma 
myocoides T-1 culture vaccine in calves aged one to 7 days 
was investigated by Stone (141). Of 5 calves so immunized; 
4 had responded 10 days later and the 5th, 20 days later. 
Staub and Boguth (134) used killed Brucella abortus 
cells and determined that the earliest responses to this 
antigen in neonatal pigs occurred at 5 to 6 weeks of age in 
those fed colostrum, while colostrum-deprived pigs did not 
respond until 10 weeks of age. 
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Using a complicated inoculation scheme, Horlein (53) 
evaluated the responses of colostrum-deprived and nonimmune, 
colostrum-fed pigs to a Brucella abortus bacterin, ovine 
erythrocytes, bovine serum and a 20 per cent egg white 
solution. The pigs were immunized weekly with a different 
antigen beginning at 3 weeks of age. A 2nd dose of each 
agent was administered 3 weeks subsequent to the primary 
dose. The colostrum-deprived pigs had no detectable response 
to a primary inoculation with Brucella abortus but responded 
to a 2nd dose at 6 to 11 weeks of age. Some pigs had a weak 
response to the first dose of ovine erythrocytes, but a much 
stronger response to a 2nd dose was noted. No response to 
bovine serum was seen following a primary inoculation while 
a 2nd one produced low titers in a number of pigs. The egg-
white solution gave no response. Colostrum-fed pigs from 
dams not immune to any of the antigens used, responded well 
to Brucella abortus and ovine erythrocytes from the youngest 
age inoculated. There was a measurable response in all to 
the first dose of bovine serum and about one-half responded 
to egg-white solution. Second doses of these antigens gave 
good seconda.ry responses. There was an increased primary 
response as the age of inoculation increased from 3 to 6 weeks. 
Pigs having no detectable maternal antibody to Salmonella 
paratyphi A were immunized with a formalinized preparation of 
this antigen (94). Those inoculated at birth produced no 
detectable response during the following 42-day observation 
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period, while of those inoculated at the 5th day of age, 
three-fourths had responded 9 to 11 days later. Inoculations 
at 7, 12, 14, and 16 days of age produced primary responses 
in all, but with increasing age there was a decrease in the 
interval from vaccination to the first detectable antibody. 
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sterzl et al. (140) inoculated 6-day-old colostrum-
deprived pigs with killed Brucella suis. Antibody was 
detected 20 days post-inoculation in this group while a CD 
group inoculated at one month or more of age had antibody 
7 days later. Pigs removed from the uterus. by hysterotomy 
7 days before term and inoculated 7 days later (at normal 
term age) produced antibody 14 days later. 
Segre and Kaeberle (119, 120) investigated the responses 
of newborn and 3-week-old pigs to diphtheria and tetanus , 
toxoids injected intraperitoneally. Newborn colostrum-
deprived pigs formed tetanus antibodies more rapidly and 
efficiently than newborn colostrum-fed pigs, while the 
opposite effect was observed with diphtheria toxoid to which 
CD pigs did not produce a detectable response. When inoculated 
at 3 weeks of age, colostrum-deprived pigs responded only 
slightly to tetanus toxoid and did not produce antibody to 
diphtheria toxoid. Colostrum-fed pigs, on the other hand, 
responded well to both antigens. The responsiveness of 
newborn pigs to tetanus toxoid was assumed due to some 
transplacental transmission of anti-tetanus antibody that 
stimulated antibody formation. 
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Pigs delivered by hysterotomy at 2 days before term 
were given erysipelas antigen at birth and were raised without 
colostrum (155). Antibody was noted 6 days later in one pig, 
and most responded in the 2nd week of life. 
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Sterzl et al. (139) measured the antibody responses to 
killed Salmonella paratyphi B and sheep erythrocytes injected 
into newborn precolostral pigs. Antibody to the sheep RBCs 
was detected on the 5th day post-inoculation, but only rarely 
had antibody to £_. paratyphi been produced by this time. 
Antibody production to this 2nd antigen had increased by 
10-15 days post-inoculation. 
Lambs 
Barr et al. (6) injected lambs at birth with alum-
precipitated diphtheria toxoid. Within 14 days 3 of 9 lambs 
had responded and by 28 days, all had titers while the 
earlier responders had increased levels. No response was 
noted to purified toxoid given alone. Adult sheep produced 
higher levels of antibody after a first and 2nd inoculation 
than did the lambs. 
The failure of newborn lambs to produce antibody to 
Salmonella typhosa, diphtheria toxoid and BCG during the 
first 42 days of life was reported by Silverstein (124). 
Richardson et al. (103) injected lambs at birth with 
killed Brucella abortus cells. No antibody response was 
4 6' 
observed in lambs inoculated with 10 , 10 , or 108 organisms, 
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but 5 of 6 l ambs receiving 109 or 1010 organisms developed 
titers of 1:40 by 12-15 days of age , and these p e rsisted for 
one to 2 weeks . Three of 4 l ambs inoculated with 1011 
organisms r esponded with maximum titers of 1:160 by days 
10-15 . Immunization with io10 organisms at one to 3 months 
of age produced titers of 1:640 to 1:1280 by 6 days post-
inoculation; these r esponses were simi l a r to those of 5-
month-old and adult sheep. 
Pups 
One of the first reports concerning the development of 
~ 
humoral antibody production in young pups was that of Sterzl 
et al . (138) . When 5-day-old pups were inoculated intra-
peritoneally with 5xl07 killed Brucella suis cells , they 
r esponded with agglutinin production by 15 to 40 days of age . 
Jacoby e t al . (56) examined the antibody r esponse s of 
n eonatal and adu l t dogs to bovine serum a lbumin (BSA) and 
ovine erythrocytes . The n eonates were stimul ated within 24 
hours of birth . No response was noted to a primary dose of 
25 mg/kg , 8 mg/kg , or 4 mg/kg of aqueous BSA in the neonates , 
and a 2nd inoculation 6 weeks later a l s o failed to elicit 
detectable antibody . In contrast , r esponses were noted in 
neonatal pups given a BSA-adjuvant emulsion . Adults produced 
antibody to both a primary and secondary stimulation with 
aqueous BSA . Neonatal pups responded as well as adults to 
ovine e rythrocytes . 
I . 
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Newborn pups and adults were injected with sheep red 
blood cells and bovine ?'-globulin (BGG) (72). The BGG was 
given either in soluble form (1 mg intravenously) or as 
an aggregate (10 mg intramuscularly). Adults and newborn 
pups responded equally well to the sheep red blood cells, but 
the pups failed to respond to the soluble BGG, while the 
adults demonstrated good primary and secondary responses. 
The neonatal pups gave a weak primary response to aggregated 
BGG and responded slowly to a 2nd inoculation. 
When one-day-old pups were injected with keyhole limpet 
hemocyanin, they produced no detectable antibodies (123). 
However, a 2nd dose of this antigen at 37 days of age 
elicited a secondary response. 
Rabbits 
One of the first reports concerned with the influence of 
age upon antibody formation was that of Freund (35). He 
injected one or 2-day-old rabbits and adult rabbits with 
equivalent amounts of killed Bacillus typhosus. Only 2 of 
10 young rabbits responded by the 5th or 6th day post-inocu-
lation, and the highest agglutinating titer was 1:80. All 
the adults had responded by this time and had an average 
titer of 1:1280. Similar age groups were also inoculated 
with sheep red blood cells, horse serum, and egg white. By 
5 to 6 days after inoculation all the young rabbits had 
responded to the sheep RBCs with an average titer of 1:103 
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versus 1:12,800 for the adults . The young rabbits also 
failed to produce precipitating antibody to horse serum and 
produced lower amounts of antibody to egg white than adults. 
Eitzman and Smith (32) found that neonatal rabbits 
responded to a single injection of bovine serum albumin (BSA ) 
at a dosage of 200 mg/ kg of body weight when given at 28 or 
more days of age and were unresponsive to this treatment at 
8 days of age or less. At 14 or 21 days of age the response 
varied; the majority injected at 14 days were unresponsive, 
while most animals produced antibody when injected at 21 
days of age. 
Soluble BSA injected intradermally into rabbits less 
than 28 days old did not induce an antibody response, while 
rabbits greater than 28 days of age did produce antibody (17 ) . 
If BSA was incorporated into FCA and inoculated into rabbits 
at birth and at 7 days of age, no response was detected in 
the first group by 16 days of age while in the 2nd group 
there was a response by 19 days of age. 
Riha (105) also studied responses to BSA as well as 
human serum albumin in young rabbits. When 5 mg was injected 
intraperitoneally, some animals inoculated at 3 or more days 
of age produced antibody 16-20 days later. Even with the 
incorporation of the antigens into FCA or aluminum hydroxide, 
no antibody formation was detected prior to the 20th day of 
life. 
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Five-day-old rabbits were injected with heat-inactivated 
Salmonella paratyphi B at a dosage of 108 organisms or 4-6 x 
109 organisms, and newborn rabbits were inoculated with 2 x 
109 organisms (137). The first group produced a response by 
30 days of age, while in the 3rd group, antibody first 
appeared as early as the 14th day, and the average onset was 
the 24th day. The 2nd group had some responses as early as 
the 9th day, while the average was the 15th day of age. 
Bellanti et al. (11) used killed Salmonella paratyphi B 
in seronegative newborn rabbits. Flagellar agglutinins 
appeared as early as 7 to 10 days post-inoculation, and most 
had agglutinins by the end of the 2nd week of life. Peak 
titers occurred at 14-25 days post-inoculation, and many 
were as high as that seen in adults. A response to the "O" 
antigen was found in only a few of the animals and to a much 
lesser degree than the response to the flagellar antigen. 
More frequent injections (3 times at 2-day intervals) 
produced higher antibody levels while increasing the number 
of organisms from 108 to 1olO produced earlier responses. 
Killed Brucella abortus injected subcutaneously into 
5-day-old rabbits (75 x 105 organisms per 100 grams body weight) 
gave antibody responses by 15-16 days post-inoculation (64). 
When injected into 10-day-old rabbits antibody was detected 
10 days later. 
Neon.atal rabbits injected with diphtheria toxoid in 
silica at birth or at 3 or 6 days of age produced antibody 
16 
by 7 days post-inoculation, while those injected at the same 
ages with diphtheria toxoid alone produced no antibody (97). 
Harris et al. (48) inoculated young rabbits with whole 
Shigella or Shigella-tryptose antigen at a dosage that 
produced good responses in adults. Rabbits 11 or 18-days-
old did not respond while 2 of 3 responded when inoculated 
at 25 days of age although with lower levels and more slowly 
than adults. By 43 days of age responses were similar to 
those of adults. With an increase in antigen dosage there 
was a decreased age of responsiveness and an increased 
quantity of antibody produced; some one and 2-day-old rabbits 
produced low levels by 14 days post-inoculation. Alum-
precipitated BGG inoculated into 3, 5, or 6-day-old rabbits 
produced responses in some that took an average of 9 days to 
reach peak titers, while all rabbits inoculated at greater 
thah 6 days of age responded, and peak titers were reached 
at 7 days post-inoculation. 
Rats --
Killed Brucella abortus administered to rats at birth 
resulted in antibody production 7 days later (46, 52). Peak. 
responses were observed at 10 days (46) and 2 weeks {52). By 
increasing the number of organisms injected into newborn or 
2-day-old rats, an increase in titers at 12-15 days post-
inoculation was noted (52). 
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Groups of rats of several neonatal ages were inoculated 
with 100..4 g of polymerized Salmonella adelaide fiagellin 
(159). Those injected at 16 days of age or later produced 
antibody after about 4 days, while those immunized at less 
than 2 weeks of age generally produced no antibody or only 
trace amounts after a few weeks. No antibody was produced 
before 20 days of age regardless of age at injection. A 
2nd dose of 10-100 ,.l\ g given at 7 or more days of age to rats 
inoculated at birth with 100 ng gave secondary responses that 
peaked 4 days later indicating sensitization to the first 
dose (122). The longer the period between the 2 inoculations, 
the greater the secondary responses. 
Maternal Antibody and the Immune Response 
The newborn of many of the common domestic species, 
including the pig, cow, sheep, and the horse, are born 
normally devoid of any antibody of maternal origin (14). A 
transfer of maternal antibody from the dam to the newborn 
occurs shortly after birth by means of ingestion of colostrum 
by the offspring. The colostrum normally contains high 
levels of maternal antibody, and after ingestion the newborn 
absorbs such antibody across its gut walls where the antibody 
enters ·the circulatory system (58). The young animal's 
capacity to absorb such antibodies from the gut contents is 
transitory, lasting only a few hours (14). The dog transmits 
some antibody to the fetus in utero, but the majority of 
transfer occurs as indicated in the species above (130). 
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The maximum circulating l evel s of maternal antibody 
attained in the n ewborn of the above spec i e s i s s imilar t o 
that found in the dam ' s serum at parturition (14) . This has 
bee n d emonstrated in the bovine species with antibody t o 
Brucella abortus (74), Salmonella typhimurium (114) , 
Salmonella dublin (51), and rinderpest virus (19) and in t he 
ovine species with ant ibody to Salmonella typhosa (73 ), 
diphtheria toxin (6) and tetanus toxin (26) . Simila r 
observations have been made in the porcine spec i e s with 
antibody to Sal monella paratyphi (93 ) and in the c anine 
spec i es with antibody to infectious canine hepatitis virus 
(25 ) a nd canine distemper virus (41). 
The maternal antibody l evel s present in the young 
animal dec line with increasing age du e to catabolism of t h e 
antibody and to eve r increas ing di l ution as the i ntravascul a r 
and extr a vascul ar pools enlarge with g r owth of the animal 
(130 , 14) . This decline usually occurs in a l inear fashion 
and , therefore , a l lows t h e calculation of maternal antibody 
h a l f-life in the n ewborn . Some h a l f -life determinat i ons of 
d i fferent antibodie s a nd immunoglobulins in the young of the 
various species are liste d in Tab l e 1. 
There is a great diversity amon g s p ec i e s with r egard to 
their catabolic rates for spec ific immunoglobul ins. The 
fract ional catabolic rate varies inve r sely with the size of 
the a nima l (1 30) and directl y with oxygen consumption . Thi s 
suggests that differences in t h e metabol ic rate is one of 
19 
Table l 
Half-life Values of Various Maternal Antibodies 
Species 
Bovine 
Porcine 
Canine 
Ovine 
and Immunoglobulins in Several Species 
Antibody (Ab) or 
Immunoglobulin 
FMD virus Ab 
rinderpest virus Ab 
diphtheria antitoxin 
Brucella abortus Ab 
Trichomonas foetus Ab 
IgG 
"fast" IgG 
IgM 
IgA 
diphtheria antitoxin 
tetanus antitoxin 
Serratia marcescens Ab 
Salmonella pullorum Ab 
Escherichia coli Ab 
IgG 
IgM 
~globulin 
IgA 
--
infectious canine 
hepatitis virus Ab 
canine distemper virus 
diphtheria antitoxin 
Half-:-life 
(days) 
15 - 19 
36.7 
16 
14 - 15 
14 - 20 
20 
18 
4 
2 
7 
9 
4.9 
4.7 
1.3 
7.5 
12 
1.3 
4.5 
7.5 
3.5 
8.6 
8.4 
28 
Reference 
(44) 
(19) 
(63) 
(68) 
(68) 
(99) 
(7 5) 
(99) 
(99) 
(66) 
(66) 
(18) 
(83) 
(100) 
(100) 
(28) 
(100) 
(28) 
(83) 
(100, 28) 
(25) 
(41) 
( 7) 
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the factors producing the wide range of species differences 
(153). It might be expected that newborn animals show 
shorter half-life values than adults, but this has not been 
demonstrated in a number of species {130). 
The various classes and subclasses of immunoglobulins 
also have different metabolic characteristics (153). Generally 
IgG is catabolized more slowly than IgM or IgA which have 
half-life values usually one-half or less than those of IgG. 
Similarly, some subclasses of IgG are catabolized more 
rapidly than others as has been noted in mice (131). 
The presence of specific maternal antibody in the 
young animal can exert a significant influence of the response 
to many different antigens {130). High levels of maternal 
antibody can block or suppress to some degree antibody 
formation in young animals that have normal responsive 
abilities. 
Henning (51) investigated the effect of killed 
Salmonella dublin administered to calves born of dams 
immunized during gestation with this agent. All calves 
received maternal anti-S. dublin "H" and "O" agglutinins 
after nursing, and, although the serum titer fell with 
increasing age, appreciable amounts of antibody remained 
until 2 to 3 months of age. Two inoculations one week apart 
were given to the calves beginning at either one to 2 days 
of age or one to 2 weeks of age. No response was noted after 
any of these.inoculations. 
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stone (141 ) inununized calves h aving various l e vels of 
antibo dy to Mycopl asma mycoides va r . mycoides with the T-1 
vaccine of t hi s agent betwee n 38 and 56 days of age . Pro -
duction of complement-fixing (CF) antibody could not be 
demonstrated in any of the animals. Even one calf immunized 
14 days aft e r maternal CF antibodies were no l onger detectable 
faile d to produce antib ody . These calves were revaccinate d 
between 58 and 86 days of age when al l were serol og ica lly 
negative , a nd a ll r esponde d by 8 to 10 d ays post-inocul ation . 
Barr et al . (7) studied the r esponse to diphtheria 
t oxoid of l ambs that recei ved maternal antibody from thei r 
immune dams . Lambs inocul ated a t 14 and again a t 42 days 
of age produced ant i toxin within 4 week s of the f i rst 
inoculation if the ir matern a l antitoxin l evels at t he t ime 
of inununization were s u fficient t o n eutra l i z e no more than 
40 p e r c ent of t h e in jected a ntigen. No r esponse s were 
obse rve d with high e r antitoxin l evels . Good secondary 
responses we re noted in a ll l ambs whose ant i toxin content 
at the first inocula tion was twi ce that s ufficient t o n eutral-
i ze a ll t h e injected toxoid . Poor secondary r esp on ses we re 
observed in those lamb s whose antitoxin l evels a t the first 
inocula tion were 2~ to 6 times that s ufficie nt to neutralize 
t h e toxoid . A few l ambs with s till high e r passive titers 
gave no active r esponse to t h e 2nd inocula tion b ut gave good 
r esponses to a 3rd dose given 9 weeks l a t e r . 
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Lambs born of ewes vaccinated with alum-precipitated 
Clostridium welchii type D toxoid and immunized with this 
preparation demonstrated different responses according to 
the level of maternal antibody present at inoculation (10). 
When a primary dose was given within 3 days of birth, lambs 
with low passive antibody levels responded, while high levels' 
blocked a response. Secondary responses were noted in 60 
per cent of the lambs given a 2nd dose, while the remainder 
demonstrated a primary response. Better secondary responses 
were noted when the interval between inoculations was 4 or 
more weeks. 
Responses to various antigens in the presence of maternal 
antibody have been studied in neonatal pigs (53). Colostrum-
fed pigs from immune sows produced no antibody to killed 
Brucella abortus at 3 to 5 weeks of age. Responses to a 2nd 
dose were lower than those recorded in colostrum-fed pigs 
from non-immune dams. There was only a slight increase in 
titer after a primary inoculation with ovine erythrocytes 
except in 6 to 8-week-old pigs which gave a good response. 
No inhibition of a secondary response to a 2nd dose was 
noted. 
Serum of newborn rabbits contains hemagglutinating 
antibody to erythrocytes of many animal species, but these 
levels decl{ne rapidly (104). When 10 per cent suspensions 
of guinea pig, sheep, rat, or dog RBCs were given to 5-day-
old rabbits with passive antibody, the antibody disappeared 
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from the circulation by the 3rd day post-inoculation; by 
the 5th day post-inoculation, antibody (actively produced) 
had appeared and peaked by 7 to 9 days post-inoculation. 
Halliday (47) immunized pregnant rats with killed 
Brucella abortus. The offspring were then inoculated at 
18 to 30 days of age with this same antigen and 4 response 
groups were observed. Those with no detectable antibody 
had a slower response than offspring of nonimmune females, 
and titers peaked at 2 weeks post-inoculation. With low 
levels present at inoculation, the response at one week 
was depressed while a peak response was again noted at 2 
weeks post-inoculation. Peak responses in these groups 
were all similar. Groups with moderate or high titers had 
decreased responses one week later and did not reach peak 
titer until 3 weeks after immunization. These responses 
were of a lower magnitude than the previous groups. 
Very low (undetectable) levels of maternal antibody 
have been associated with enhancement of the immune response 
in young animals (119, 120, 121). Segre and Kaeberle (120) 
noted that in newborn colostrum-deprived pigs, enhancement 
of responses to tetanus or diphtheria toxoid occurred when 
one ml of 1:10,000 diluted swine serum from pigs hyperimmunized 
with tetanus toxoid and tiphtheria toxoid was injected with 
the toxoid. Similar results were recorded in 3-week-old 
pigs (119, 121). The inoculation of 3-week-old colostrum-
deprived pigs with tetanus and diphtheria toxoids mixed with 
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50 ml of swine serum from 7 to 8-week-old colostrum-deprived 
pigs immunized 2 weeks previously with tetanus and diphtheria 
toxoid resulted in enhanced antibody responses (119). 
Increased responsiveness was also noted when 500 mg of gamma 
globulin from 4 to 14-week-old CD pigs was injected with the 
toxoids (121). 
Neonatal Immunity in the Foal 
An early paper on passive immunity of domestic animals 
by Mason et al. (81) proposed that the foal had no immunity 
(i.e •. , antibody) priortobirth. They examined the serum of one 
newborn foal from a mare with a "natural" diphtheria anti-
toxin titer of J.25 units/ml and found it to contain no 
demonstrable antitoxin. They administered sheep serum 
containing lamb dysentery antitoxin and equine tetanus anti-
toxin orally immediately after birth and noted that both anti-
body types were absorbed within 3 hours. In the same year 
Bardelli (5) also reported that the serum of a newborn foal 
was negative for tetanus antitoxin before nursing but became 
positive after nursing its dam's colostrum which had a high 
antitoxin titer. 
Alexander and Mason (1) worked with a group of pregnant 
mares vaccinated with neurotropic horsesickness vaccine. 
They found that presuckling serum samples from foals of dams 
with serum antibody to the agent were negative for such 
antibody. In less than 30 hours after birth the serum 
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antibody levels in the foals had reached a concentration at 
least equal that of their dam's. The titer gradually 
decreased with age, and the duration of the decl,ine was pro-
portional to the original 30-hour titer. The ant:ibody 
present usually persisted for about 6 months. During the 
period that anti-horsesickness antibody could be detected and 
for some unknown length of time after apparent disappearance, 
the inoculation of routine horsesickness vaccine had no 
immunizing effect. The passively acquired immunity protected 
foals against the virulent pantropic virus for 157 days but 
not for 23·9·days after birth. 
Some slight transmission of tetanus antitoxin to the 
foal prior to nursing was reported by Lemetayer et al. (69, 70). 
These foals were offspring of mares hyperimmunized against 
tetanus. They found, however, that the foal acquired most 
tetanus antitoxin subsequent to nursing and that the serum 
levels of antitoxin attained by the foals approximated that 
of their dam's serum titer. 
Bruner et al, (22) used Salmonella abortus~egui· antigen to 
hyperiminunize mares prior to foaling. Although at parturition 
the mares had very high serum antibody levels against this 
antigen (1:5000), no antibody could be detected in the foals 
before nursing. At 12 hours of age the foals anti-S. abortus-
egui titer was 1:1000. By one, week the titer had fallen to 
' 
1:500, and it remained at this level through one month of age. 
At 6 months the antibody levels in the foa'ls were undetectable. 
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Bruner e t a l . (21) attempted to d etermine the approximate 
age when the foa l was no l onger capable of absorbing maternal 
antibody . Using high tite r anti-Salmonella abortivoequina 
serum administered orally to foa l s at different intervals 
after birth, they found that foals no l onger acquired detec-
table serum titers at 24 t o 36 hours of age . 
Lemetayer e t al . (71) determined that the l e vels of 
a ntitoxin in foals born of ma r es i mmunized again s t t e tanus 
i n t h e l ast weeks of gestation were protective u p to 30-50 
days of age . They suggested immunizing foa ls with alum-
precipitated t etanus anatoxin a t 6 weeks of age . Responses 
to the a ntigen a t this age were comparab l e to those of the 
adult h orse , and t h e maternal a ntitetanus antibody present 
did not impai r t h e estab l ishment or duration of immunity . 
The y a l s o suggest e d immunization of the darns routinely in 
l ate gestat i on with this agent . 
A r eport (110) on the longevity of maternal t e tanus 
a ntitoxin in the n eon atal foa l i ndicated tha t, with ma r e s 
hype rirnrnunized with a djuvante d tetanus toxoid in late 
gestation , protection was afforde d the ir foa l s after nurs ing 
fo r as long as 6 months. One foal deprived of colostrum 
l acked protective antitetanus l evel s . 
In a study (23 ) of 18 foa ls born of mar e s seropositive 
to equine in fectious a n emia virus, a lmost a ll the foals were 
f ound to b e seropos itive upon initial examinat ion after birth 
and r emained so until 65 to 182 days of age . 
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Jeffcott (61) hyperimmunized 6 mares during gestation 
with Clostridium welchii type A toxin. Traces of antitoxin 
were found in prenursing sera, but the titers rose rapidly 
after nursing to about one-half the dam's serum titer. The 
levels then fell so that by 4 weeks of age they were 35 per 
cent of peak values. They were no longer detectable at 4 
months of age. 
Schutzler (117, 118) reported that 5 of 10 foals born 
of dams hyperimmunized with aluminum hydroxide-absorbed 
tetanus toxoid showed an antitoxin titer of 0.01 IU/ml 
before nursing. The foals showed no response when immunized 
at one (prenursing), 4, 7, 14, or 21 days of age. However, 
in several of these foals, sensitization occurred because 
a 2nd inoculation given at 5, 6, 7, or 12 weeks of age resulted 
in a rapid response. 
Recent work by Jeffcott (57, 59, 60) has been directed 
to the mechanism and duration of the transfer of maternal 
antibody to the foal. Intestinal absorption has been shown 
to be the primary if not the only transfer mechanism. A 
decline in absorptive ability occurs after birth, and anti-
body absorption ceases by 24 hours of age. Levels of maternal 
antibody and immunoglobulin are also greatly decreased in the 
maternal colostrum produced at 24 hours after parturition 
(59, 60). 
Studies of the transfer of maternal antibody in the 
equine have also been made by evaluating circulating 
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irnmunoglobulins in the neonatal foal. Excellent reviews 
summarizing the literature on equine irnmunoglobulins have 
been prepared by McGuire et al. (77) and Montgomery {88). 
The horse possesses at least 8 antigenically distinct 
groups of immunoglobulins (108). There are 3 subclasses of 
IgG - IgGa, IgGb, and IgGc. The horse also possesses IgM 
and IgA and 2 classes unique to the equine species, IgG (T) and 
aggregating irnmunoglobulin (AI). A summary of their proper-
ties are presented in Table 2. 
IgG(T) is found in predominant levels in tetanus and 
diphtheria antitoxins. Aggregating irnmunoglobulin is found 
in high levels in anti-pneumococcal polysaccharide serum 
and is composed of noncovalently-linked, salt-dissociable 
aggregates. The classification and nomenclature of equine 
irnmunoglobulins are currently open to discussion (88). 
In 1943 Polson (98} reported that newborn foal serum 
had only traces of,B-globulin and an absence of "?'-globulin. 
By 5 days of age, both levels appeared to have had greatly 
increased. 
Rouse (111) reported the levels of IgG, IgG(T), and IgM 
in foals at various ages after birth. Two groups of foals 
were used - 9 Thorouglilireds and 9 Shetland-type ponies. No 
irnmunoglobulins were detected before colostrum ingestion, but 
within 12 to 24 hours after nursing the levels of all irnmuno-
globulins studied had risen to within the adult range. For 
the next one to 2 months, the concentrations decreased rapidly 
Table 2 
Some Properties of Equine Immunoglobulins 
Immunoglobul i n 
Class 
Molecular 
Weight 
IgG a , b, c 
IgG (T) 
I gM 
IgA 
152 , 000 
152 , 000 
1 , 000 , 000 
150 , 000- 700 , 000 
Most 350 , 000(di mer) 
Sedimentation 
Coefficient 
6 . 7S 
7 . ls 
19 . 8S 
(five 6 . 3S 
monomers) 
variable 
AI variable 
150 , 000 ave . 
9S - 15S as 
an aggregate 
(6 . 3S monomer) 
aimmunoglobulin levels expressed in mg/100 ml . 
Electrophoretic 
Mobility 
Ave. Serum 
Cone . in 20 
Shetlands (88) 
1334a (IgGa) 
821 
120 
153 
39 
30 
after which the levels remained constant for a period of 
time that varied with each immunoglobulin class. Immuno-
globulin concentrations then increased with IgM levels 
rising first, followed by IgG(T) and later by IgG. Immuno-
globulin concentrations increased at an earlier age in the 
Shetland-type pony foals than in the Thoroughbred foals. 
Serum concentrations of IgG, IgA, IgM, IgG(T) and 
aggregating immunoglobulin (AI) were measured in 3 Quarter 
Horse and 5 Shetland pony mares at parturition and in their 
foals at various ages after birth (76). Some IgM was found 
in the prenursing sera of 4 foals and some IgG was also 
found in one of these. All 5 immunoglobulins were absorbed 
and reached maximum levels at 24 hours. IgG was absorbed 
more rapidly and to a concentration more nearly equal the 
dam's levels than the other classes. Concentrations began 
to decrease after this time with minimum levels of IgG and 
IgG(T) occurring at 30 to 60 days of age. It was concluded 
that synthesis of IgG, IgG(T), and IgA began within 24 days 
of birth, and that synthesis of IgM probably began_ before 
birth. No differences were noted between the Quarter Horse 
and Shetland pony foals. 
~effcott (61) followed the 'f-globulin levels in 3 groups 
of foals from birth to one year of age. One group nursed 
normally from birth, a 2nd received supplementary colostrum 
and hyperimmune serum during the first 30 hours of life, and 
a 3rd group was deprived of colostrum. All foals were 
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agammaglobulinemic at birth, and in both colostrum-fed groups, 
the 'J"-globulin levels peaked 12-18 hours later. The peak 
values were a little lower than those of their dams. The 
levels in the first 2 groups then decreased to lowest values 
at 4 to 5 weeks after which they again rose to plateau at 6 
to 8 months of age. The colostrum-deprived foals remained 
agammaglobulinemic until 2 weeks of age. The levels then 
rose steeply until 7 to 8 weeks of age after which they 
'remained steady and were similar to values seen in the 
other 2 groups at 6 to 8 months. 
Recently there have been 2 reports of equine fetal 
responses to antigenic stimulation. Martin and Larson (79) 
injected 5 equine fetuses with T2 coliphage at 200 days 
gestation. The fetuses were then delivered by hysterotomy 
10 days later, and fetal serum samples were taken. All 5 
fetuses had developed viral neutralizing titers by the time 
of delivery. No neutralizing antibody was detectable in the 
mares at this time. Fetuses of 9 mares at 8 to 9 months 
gestation were given injections of Venezuelan equine 
encephalomyelitis (VEE) virus vaccine (89). Serum from the 
9 foals before nursing had VEE'-serum neutralizing (SN) 
titers that were 3 to 10 times greater than those found in 
mature horses similarly vaccinated. No effect was noted on 
the mares' VEE-SN titers. 
Reilly and MacDougall (102) studied the metabolism of 
1 25I-labelled equine IgG in foals beginning at 3 days of age. 
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The apparent plasma half-life of the labeled immunoglobulin 
was 23 days ± 4.5 days. Half-life values of 23 days for 
gamma-globulin and 20 days for Clostridium welchii type A 
antitoxin were calculated by Jeffcott (61) in 8 foals from 
birth to 4 weeks of age. He also reported a shorter half-
life (18 days) for gamma-globulin in foals fed supplementary 
colostrum at birth and, therefore, possessing higher gamma 
globulin levels. 
Half-life determinations in adult horses have included 
diphtheria antitoxin (19-26 days) (42), l31I-labelled "gamma 
globulin" (11.·0 days) (100) and Il31 labelled IgG (14.3 days) 
(92). In addition, the latter study by Nansen and Riising 
(92) indicated that the catabolic rate of IgG was directly 
proportional to.the plasma level of IgG. 
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EXPERIMENTAL PROCEDURE 
Animals 
This experimentation, conducted over a 2 year period, 
involved the use of a large group of Shetland pony mares 
and their offspring and a small group of Quarter Horse mares 
and their offspring. 
In 1973 a group of 29 pregnant Shetland pony mares was 
obtained and individually identified by freeze branding. This 
group was kept on pasture isolated from contact with other 
horses. Three pregnant Quarter Horse mares owned by the 
D~partment of veterinary Clinical Sciences, Iowa State 
University, Ames, Iowa were also utilized. They were housed 
during gestation with other mares owned by the Department. 
·When the mares appeared to be near parturition, they 
were transferred to a separate facility for observation and 
foaling. Thirty-one live foals and one dead foal were born 
without complications. The foals were given the same number 
as that of their dam for identification purposes. 
At birth the Shetland foals were placed into one of 2 
groups -- those allowed to nurse their dams in a normal 
fashion (colostrum-fed or CF) or those not allowed to nurse 
(colostrum-deprived or CD). Colostrum deprivation was 
accomplished by placing a square piece of rubber sheeting 
over the mare's udder and securing it to her by means of a· 
harness. Parturition of the mares was attended whenever 
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possible. Seventeen of the 28 live Shetland foals were 
deprived of colostrum for the first 72 hours after birth. 
None of the foals of the Quarter Horse mares were deprived 
of colostrum. 
The colostrum-deprived foals were fed a commercial 
. 1 
equine milk replacer diet every 6 hours until they were 72 
hours of age, following which they were allowed to nurse. 
The dams of the CD foals were milked out by hand every 6 
hours during the 72 hour period after parturition. 
The CD foals were put on antimicrobial prophylactic 
therapy at 6 hours of age, and this was continued until they 
were one week old. At the beginning of the project the 
regimen included oral tetracycline2 and oral sulfamethazine3 
and a parenteral penicillin-dihydrostreptomycin cornbination4 • 
Loss of 5 foals (one from Actinobacillus equuli septicemia 
and 4 from Escherichia coli septicemia) prompted a change in 
the antimicrobial regimen. Subsequently CD foals received 
. 5 6 
oral chloromycetin and ora~ neomycin and a parenteral 
1 Foal-Lac, Borden Chemical, Norfolk, Virginia. 
2 Cosa-Terramycin, Pfizer, Inc., New York, New York. 
3 Sulf.amethazine U. S .P. Powder, Veterinarian Specialties, 
Inc., Cedar Rapids, Iowa. 
4 
Pen-Di-Strep, Diamond Laboratories, Des Moines, Iowa. 
5 Tevcocin Oral, Tevcon Industries, Inc., Omaha, Nebraska. 
6 
Biosol Liquid, The Upjohn Co., Kalamazoo, Michigan. 
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1 
combination of trimethoprim-sulfadiazine as well as the 
penici.llin-dihydrostreptomycin combination. The CD foals 
seemed much more susceptible to infectious agents, especially 
E. coli during the first days of life, but the second 
described prophylactic treatment regimen appeared to effec-;~ 
tively prevent severe disease in the remaining foals. Of the 
17 foals deprived of colostrum, 12 survived and were used in 
later experimentation. 
When the foals were one to 3 weeks of age, they were 
moved back to pasture along with their dams. They were held 
together in one group for the duration of the project. The 
Quarter Horse mares and their foals were held in a separate· 
lot isolated from other horses during the project. 
In 1974 a group of 33 pregnant Shetland pony mares 
was obtained. Eighteen of these mares had been used in the 
1973 group. The remainder were identified as described 
previously. These mares were kept on pasture isolated from 
contact with other horses. 
Upon observation of impending parturition, the mares were 
moved to another facility for observation and foaling. Thirty-
three live foals were born with no noted complications. 
All foals were allowed to nurse normally after birth, 
and n·o antimicrobial agents were administered. At about one 
week of age the foals and their dams were moved back to 
1 
Tribrissen, Burroughs, Well.come and co., London, England. 
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pasture where all were kept in one group. One foal died at 
7 weeks of age from acute Actinobacillus eguuli nephritis. 
Antigens 
Brucella - HSA 
An antigen containing at least 10 x 109 killed Brucella 
abortus cells, 10 mg of human serum albumin and 0.04 ml of 
a 50 per cent bentonite suspension per ml was employed. This 
antigen was identified as Brucella-HSA. To produce this 
antigen a commercial preparation of lyophilized live Brucella 
abortus Strain 19 ,cells1 was reconstituted with 19 ml of the 
sterile diluent supplied with the preparation. The bacteria 
were killed by heating in a 65°c water bath for one hour. 
Five ml of human serum albumin (Cohn's fraction v) 2 mixed to 
' 
a concentration of 50 mg/ml in normal saline solution (NSS) 
were added to this suspension. Also added was a fraction of 
sterile, washed bentonite3 prepared by differential centri-
fugation and resuspended in an equal volume of NSS. 
1 Brucella Abortus Vaccine, Jensen Salsbery Laboratories, 
Kansas City, Missouri. 
2 Miles Laboratories, Inc., Kankakee, Illinois. 
3 Fisher Scientific Co., Fair Lawn, New Jersey. 
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Tetanus toxoid, killed eguine encephalomyelitis virus 
A commercial product composed of tetanus toxoid and 
inactivated avian tissue culture origin Western and Eastern 
equine encephalomyelitis virus (Equiloid1 ) was used as 
supplied by the manufacturer. 
Immunization 
In 1973 the pregnant Shetland pony mares were divided 
into 3 groups. One group of 16 mares was immunized with 
Brucella-HSA. Each mare received a dose of 2.5 ml 
subcutaneously and 2.5 ml intramuscularly in the neck 
region. The 2nd group of 9 mares was inoculated with Equiloid 
given intramuscularly in the neck region. A 3rd group of 
4 mares was not immunized. 
Most mares in the Brucella-HSA immunized group were 
given at least 3 inoculations before parturition. The 
intervals between Brucella-HSA inoculations were approximately 
4 months between the first and 2nd doses and one month 
between the 2nd and 3rd doses. Additionally, 4 mares were 
given a 4th inoculation about 5 weeks after their 3rd dose. 
Two mares received a single inoculation at 2 to 3 weeks 
berore parturition. 
1 Equiloid, Fort Dodge Laboratories, Fort Dodge, Iowa. 
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Most mares ~n the Equiloid immunized group received 4 
injections before foaling. The interval between the first 
and 2nd doses was approximately 7 weeks and the 3rd dose 
followed the 2nd by approximately 3 months. The 4th injection 
was given about 5 weeks after the 3rd. Four mares were 
given only 2 inoculations before parturition. 
The Quarter Horse mares were given a single injection 
of Equiloid·prior to parturition. 
An immunization format for the foals of these mares is 
presented in Table 3. Immunizations with either Brucella-HSA 
or Equiloid were made at one, 2, 4, 8, or 12 weeks of age. 
Those animals immunized one·, 2, 4, or 8 weeks of age were 
given a 2nd dose at 12 weeks of age. Most foals were 
immunized with both products, but the primary immunizations 
with different products were always separated by at least 
2 week intervals except in 2 foals immunized at 12 weeks of 
age. 
Table 4 indicates the number of foals in each age group 
immunized with the various antigens. 
Blood samples were collected from the mares at parturition 
and from their foals at birth and before nursing whenever 
possible. Foals were bled at 24 hours, 72 hours and one week 
of age and weekly thereafter until the foals were 15.weeks 
old. A 20 ml sample of blood was collected in an evacuated1 
1 . 
B-D Vacutainer Tubes, Becton, Dickinson and Co., · 
Rutherford, New Jersey. 
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Table 3 
Irnrnunizat.ions ·of 1973 Foals 
Foal Colostrum fed (CF) or 
Number Colostrum deprived (CD) 
1 CD 
2 . CF 
3 CF 
4 stillborn 
5 CD 
6 CD 
8 CF 
9 CF 
10 CD 
11 CD, died 
13 CD 
15 CD, died 
16 CD 
17 CD, died 
18 CD 
19 CD 
20 CD 
21 CF 
23 CD, died 
28 CF 
29 CF 
30 CF 
33 CD, died 
41 CD 
42 CF 
43 CF 
44 CD 
45 CD 
46 CF 
B. Quarter Horse Foals 
101 
102 
103 
CF 
CF 
CF 
Age at Primary & Secondary 
Immunizations 
Brucella-HSA 
? 12 
8 12 
4 12 
---------
1 12 
1 12 
8 12' 
1 12 
8 12 
---------
4 12 
---------
12 -
---------
12 -
8 12 
4 12 
2 12 
---------
8 12 
- -
- -
---------
2 
1 
2 
1 
2 
2 
12 
4 
2 
12 
12 
12 
12 
12 
12 
12 
12 
(weeks·} 
Eguiloid 
4 12 
1 12 
2 12 
-------
8 12 
8 12 
1 12 
8 12 
1. 12 
-------
2 12 
-------
4 12 
-------
12 
1 12 
2 12. 
4 12 
-------
1 12 
8 
2 12 
-------
1 
4 
4 
8 
4 
1 
12 
2 
4 
12 
12 
12 
12 
12 
12 
12 
12 
Table 4 
Number of Foal·s d.n Immunization Groups· (1973) 
Equiloid Immunized Dams Brucella-HSA Immunized Dams 
Immunizations CF Foals CD Foals CF Foals CD Foals 
I •. Equiloid 
A. One week 1 2 3 1 
B. 2 weeks 1 1 2 1 
c. 4 weeks 2 1 2 2 
D. 8 weeks 1 1 1 2 
E. 12 weeks *" 0 
1. primary 
immunization 1 0 0 1 
2. secondary 
immunization 5 5 7 6 
II. Brucella-HSA 
A. One week 2 1 0 2 
B. 2 weeks 1 2 3 1 
c. 4 weeks 1 1 1 l 
D. 8 weeks 1 1 l l 
E. 12 weeks 
1. primary 
immunization 1 0 0 2 
2. secondary . .. 
·immunization 5 5 5 7 
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t ube from t h e jug ular vein wi t h a one a nd one-half i nch 
20 gauge need l e . About 4 hours af t e r c ol l e ction the tube s 
we re c e ntrifuged at 1000 g for 10 minutes . Serum was 
harves t e d , divided into 5 a l iquots a nd sto r e d a t -20C . 
The 1974 pregnan t Shetl a nd pony ma re group was 
immunized in the l ast h a lf of ges tation with one or more 
of the a ntigens employe d . The i mmunizatio n sche dule was 
designe d to produce groups of mares with different speci f ic 
a nti body l eve ls at p a r t uri tion . An attemp t was made by th is 
means to create groups of foa l s with different specific 
maternal ant ibody titers . Thirteen mares r e ceived one 
injection , 14 mares received 2 inj ections , and o ne mare 
received 3 inj ecti ons of Equiloi d prior to parturition . 
El e ven mares received one inj ecti on , and 4 mares received 
2 inj ections of Brucel la- HSA befor e foaling . The inte rvals 
between inocu l ati ons wi t h these products we re at l east one 
month . 
The fo a l s we r e immunize d at various ages with the 3 
antigens as indicate d in Tabl e 5 . Primary immunizat ions 
with Bruce l la-HSA were conducted a t the ages of 2 weeks 
( 2 foa l s ) , 4 weeks (6 foals ) , 8 weeks (one foa l) , 10 week s 
(19 foa l s ) , 1 1 week s ( 2 foa l s ) and 1 2 weeks (2 foa l s ) . 
Secondary immunizations were usual l y given 4 weeks later . 
. 
Primary immunizations wi t h Equiloid we r e administered at 2 
weeks (one foa l ) and 8 weeks (3 1 foa l s ) . Secondar y 
immunizations were ma de 4 weeks l ate r. 
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Table 5 
Inununizations of 1974 Foals 
Age at Primary and secondary Inununizations (weeks) 
Foal Number Brucella-HSA Eguiloid 
1 10 14 8 12' 
2 10 14 8 12 
3 10 14 8 12 
4 11 15 8 12 
5 10 14 8 12 
6 10 14 8 12 
8 10 14 8 12 
9 4 9 8 12 
10 10 14 8 12 
11 10 14 8 12 
13 died 
14 10 14 8 12 
15 10 14 8 12 
17 4 9 8 12 
18 8 12 8 12 
19 4 8,12 8 12 
20 12 16 8 12 
23 10 14 8 12 
24 2 7 8 12 
25 4 8,12 8 12 
26 10 14 8 12 
29 2 6 8 12 
31 10 14 8 12 
32 10 14 8 12 
33 4 8 8 
34 10 14 8 12 
35 10 14 8 12 
37 10 14 8 12 
38 4 9 8 12 
52 10 14 2 6 
54 12 -- 8 12 
56 10 14 8 12 
58 11 15 8 12 
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Blood samples were collected from the mares at 
parturition and their foals at birth; foals were bled prior 
to nursing when possible. Subsequent samples were taken at 
72 hours and one week of age and weekly thereafter until the 
foals were 17 weeks old. A 20 ml sample of blood was taken 
as described previously. Centrifugation and storage of the 
serum was also done as described above. 
Serological Testing 
The macroscopic tube agglutination test (133) was used 
to determine the presence of agglutinating antibody to 
Brucella abortus. Brucella antigenl was diluted 1:100 in 
0.5 per cent phenolized NSS. The serum samples were thawed 
in a 37C water bath and inactivated in a 56C water bath for 
30 minutes. Serial 2-fold dilutions of the sera were made 
in 0.5 ml volumes of NSS starting with a 1:10 dilution. An 
equal quantity of the prepared tube antigen was added and 
mixed by gentle shaking. Tests were incubated overnight in 
a 37C waterbath and read the next morning. A positive test 
was indicated by a visible agglutinate present at the bottom 
of the tube. The titer was expressed as the reciprocal of 
the highest dilution giving a positive reaction. 
A passive hemagglutination test (33) utilizing the 
1 Brucella Antigen (tube), provided by USDA, ARS, Animal 
Health Division, Diagnostic Services - Diagnostic Reagents, 
NADC, Ames, Iowa. 
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microtiter technique1 was used for the determination of 
antibodies to human serum albumin. Human serum albumin 
(Cohn's fraction V) was dissolved in NSS at a concentration 
of 25 mg/ml. Sheep erythrocytes were washed 3 times in NSS. 
An aliquot of 0.1 ml of a 50% glutaraldehyde solution2 was 
added to 4.9 ml of NSS. To 0.25 ml of washed, packed sheep 
erythrocytes was added 0.4 ml of the human serum albumin 
solution and 0.8 ml of the glutaraldehyde preparation. This 
mixture was allowed to incubate at room temperature for one 
hour and was then washed 3 times in NSS. It was resuspended 
in 45 ml of normal rabbit serum diluent (one per cent 
inactivated, sheep red blood cell-absorbed rabbit serum in 
NSS). A 0.1 ml aliquot of this suspension was diluted with 
4.9 ml of normal rabbit serum diluent. The optical density 
of this suspension was measured in a spectrophotometer3 at 
540 millimicrons using tubes with a 10.0 mm internal diameter 
and the optical density was adjusted to 0.120 by the addition 
to or removal of normal rabbit serum diluent from the original 
suspension. Sensitized sheep RBCs were prepared fresh each 
day on which the tests were conducted. 
1 Microtiter, Cooke Engineering Co., Alexandria, Virginia. 
2 
50% Glutaraldehyde Solution W/W, Fisher Scientific Co., 
Fair Lawn, New Jersey. 
3 Spectronic 20, Bausch and Lomb, Inc., Rochester, New 
York. 
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The sera to be tested.were thawed in a 37C water bath and 
inactivated in a 56C water bath for 30 minutes. A 0.5 ml 
aliquot of each serum sample was absorbed with 2.5 ml of a 
20 per cent washed sheep erythrocyte suspension for one hour. 
Serial 2-fold dilutions were made in microtiter plates using 
one per cent normal rabbit serum diluent and starting with 
a 1:10 dilution. one drop (0.05 ml) of the sensitized 
erythrocyte suspension·was added to each serum dilution. A 
positive serum of known titer and a known negative serum 
were included as controls. The sera and sensitized RBCs 
were mixed by scratching the bottom of the microtiter plates. 
The sensitized cells were allowed to settle at room temperature, 
and the test read in 4 to 6 hours. A positive test was 
indicated by a mat of cells covering the bottom of a micro-
titer plate well and a negative test by collection of the 
cells in a button at the bottom of the well. The titer was 
expressed as the reciprocal of the highest dilution giving a 
positive reaction. 
A passive hemagglutination test (33) utilizing the 
microtiter technique was used for the determination of anti~ 
bodies to tetanus toxoid. A concentrated fluid tetanus 
toxoid, L-1111 , c~ntaining 400 LF/ml, was used as the antigen. 
The techniques used in this test were the same as those 
described in the previous procedure for HSA except for the 
1 Provided courtesy of Dr. Donald Baldwin, Fort Dodge 
Laboratories, Fort.Dodge, Iowa. 
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quantity of tetanus tox~id (1.6 ml) used as antigen in the 
sensitization of the sheep RBCs. The titers were expressed 
as the reciprocal of the highest dilution giving a positive 
reaction. 
A hemagglutination inhibition test (27) utilizing the 
microtiter technique was used to detect antibody to both 
Eastern and Western equine encephalomyelitis virus. The test 
was essentially identical for both antibody types with the 
only difference being in the antigen used in the particular 
test. Each test employed killed equine encephalomyelitis 
virus harvested from suckling mouse brains. 
Adult male white goose red blood cells (RBCs) were 
washed 4 times in Dextrose-Gelatin-Verona! solution (DGV), 
resuspended with 3 volumes of DGV and held overnight at 4C. 
A 0.5 ml aliquot of this suspension was diluted with 19.5 ml 
of NSS. The optical density of this suspension was measured 
in a spectrophotomerl at 490 millimicrons using tubes with a 
10.0 mm. internal diameter, and the optical density was 
adjusted to 0.450 by the addition to or removal of DGV from 
the suspension. This standardized suspension was stored at 
4C until use. For use in the tests, one ml of the standardized 
RBC suspension was mixed with 23 ml of DGV. 
The lyophilized antigens were rehydrated in distilled 
water, diluted 1:10 in chilled 0.4 per cent bovalbumin-borate-
- 1 Coleman Jr., Coleman Instruments Corp., Maywood,-
Illinois. . .. 
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saline, pH 9.0 (BABS) and allowed to dissociate for one hour. 
The antigen solutions were titrated in 0.4 per cent BABS to 
determine the highest dilution causing complete or partial 
hemmagglutination of 0.05 ml of the goose RBC preparation. 
This represented one unit of hemagglutinin (HA). The stock 
antigen solution was then diluted with 0.4 per cent BABS to 
give a final concentration of 4 to 8 HA units in 0.025 ml of 
the solution. 
Before· each group of tests were run, the antigen solution 
was titrated to determine its hemagglutinating activity. If 
there was a decrease in activity to less than 4 units of HA, 
more stock solution was added to increase the HA units to the 
appropriate level. 
Sera were ·thawed in a 37c· ·water bath and inactivated in 
a 56C water bath for 30 minutes. A 0.2 ml aliquot of each 
serum sample was diluted with 0.8 ml of borate saline (pH 9.0). 
One ml of a 25% suspension of acid washed kaolin1 in borate 
saline '(pH 9.0) was added. The serum-kaolin mixture was 
vigorously shaken at intervals during a 20 minute incubation 
period at room temperature. The mixture was then centrifuged 
and the supernatant fluid removed. This supernatant fluid was 
considered to be a 1:10 dilution of the sera and was then 
absorbed with one drop (approximately 0.05 ml) of a 50 per 
cent washed goose RBC suspension in DGV. This combination was 
1 
Fisher Scientific Co., Fair Lawn, New Jersey. 
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mixed well and allowed to stand 20 minutes at 4C with 
occasional shaking. It was then centrifuged, and the 1:10 
diluted serum was removed for testing. 
Two-fold serial dilutions of the diluted sera were made 
in microtiter plates using 0.025 ml of 0.4 per cent BABS per 
microtiter well as diluent. To each well was added 0.025 ml 
of the appropriate antigen. A control row containing the 
first 2 dilutions of each serum was included for detecting 
any nonspecific agglutination of the cells by the serum. To 
each of these wells 0.025 ml of 0.4 per cent BABS was added 
in place of the antigen. Also included as controls were a 
positive serum of known titer and a known negative serum. 
The serum-antigen mixtures were incubated overnight at 4C. 
To each well was added 0.05 ml of the goose RBC suspension, 
and the bottom of the microtiter plates were scratched to 
mix the contents. The plates were incubated for 30 minutes 
at 37C and read. Hemagglutination was indicated by a mat of 
cells covering the bottom of a microtiter plate well. 
Hemagglutination inhibition was noted where a button of RBCs 
had formed at the bottom of a well. Incomplete hemagglutin-
ation was read as a ring of RBCs around a partially formed 
mat of RBCs. The titer was expressed as the reciprocal of 
the highest dilution of serum inhibiting hemagglutination 
except where incomplete hemagglutination occurred at the 
endpoint region. In this case the reciprocal of the first 
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dilution to cause incomplete hemagglutination was 
considered to be the titer. 
so 
RESULTS 
Transfer of Maternal Antibody 
Serum samples taken from foals before nursing were 
assayed for the presence of antibodies to Brucella abortus 
Sl9, tetanus toxoid, human serum albumin and Eastern and 
western equine encephalornyelitis virus. Table 6 illustrates 
the serum titers for each antibody type in the mares at 
parturition versus those in the foals prior to nursing. 
In no instance were antibodies to Brucella abortus Sl9, 
tetanus, or HSA found by the serological tests employed in 
foal pre-nursing sera. In the case of WEE and EEE a number 
of animals demonstrated titers at 1:10 and a very few at 
1:20 or 1:40. These were considered to be nonspecific in 
nature and related to the specific serological procedure 
used, i.e., hemagglutination inhibition. 
The average of the foals' passive antibody titers to 
the above antigens at 24 hours and 72 hours of age were 
compared to those of the darns at the time of parturition. 
These results are illustrated in Figure 1. A somewhat 
similar comparison summarizing larger groups of animals is 
presented in Figure 2. 
colostrum-deprived foals were allowed to nurse their 
dams beginning at approximately 72 hours of age. None of the 
CD foals exhibited detectable antibody to any of the 5 antigens 
at one week of age. 
51 
Table 6 
Titers of Mares . at ·Parturition and Foals Before Nursing 
Antibody to: 
. v·-." •,- ·· .•• 
Titers B. abortus Tetanus HSA EEE WEE 
0 l/33a.. 9/29 7/32 10/11 5/10 
1:10 0/0 0/0 1/0 10/16 5/17 
1:20 1/0 1/0 3/0 2/2 0/1 
1:40 6/0 1/0 1/0 2/2 2/0 
1:80 4/0 1/0 1/0 2/0 1/0 
1:160 1/0 1/0 2/0 3/0 2/0 
1:320 2/0 0/0 0/0 0/0 3/0 
1:640 4/0 2/0 2/0 2/0 1/0 
1:1280 6/0 1/0 0/0 0/0 1/0 
1:2560 3/0 2/0 0/0 0/0 2/0 
1:5120 3/0 2/0 5/0 0/0 1/0 
1:10240 0/0 5/0 3/0 0/0 2/0 
1:20480 2/0 4/0 7/0 0/0 3/0 
a 
Number of mares wit~ Number of foals with 
indicated titer . indicated titer 
. 
Figure 1: A bar graph illustrating the average serum titer of the dams at 
parturition and the corresponding average serum titers of 
colostrum- fed foals at 24 and 72 hours of age . Titers compared 
include antibody to tetanus toxoid (17 pairs of dams and foals) , 
We stern and Eastern equine encephalomyelitis virus (14 pairs), 
Brucella abortus 519 (13 pairs) , and human serum albumin (12 pairs) . 
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Figure 2: A bar graph illustrating the average serum titer of the dams at 
parturition and the corresponding average serum titers of 
colostrum- fed foals at 72 hours of age. Titers compared include 
antibody to tetanus toxoid (38 pairs of dams and foals ) , Western 
equine encephalornyelitis virus (40 pairs) , Eastern equine 
encephalornyelitis virus (33 pairs) , Brucella abortus 519 (27 
pairs) and human serum albumin (23 pairs) . 
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Response to Immunization 
Effect of colostrum deprivation 
A comparative study using 2 groups of foals was made to 
evaluate the effect of colostrum deprivation on.the humoral 
antibody response. One group was colostrum-deprived; the 
other was composed of foals that had nursed but were offspring 
of dams that lacked detectable circulating antibody to the 
particular antigen. This 2nd group was seronegative for such 
antibody from birth to the first immunization. Comparisons 
were made between foal groups of different ages at the time 
of primary immunization. 
Comparative responses to Brucella abortus Strain 19 at 
one, 2, 4, 8, and 12 weeks of age (Figures 3-7) demonstrated 
that agglutinating antibody to Brucella abortus was 
detectable by 7 days after inoculation. Peak titers were 
noted one or 2 weeks after immunization and levels subsequently 
decllned. 
In the one-week-old foals a 2nd immunization was given 
at 12 weeks of age. This resulted in an immediate rise in 
titer which was highest one week post-inoculation (Figure 3). 
In the foal groups that were 2 or 4 weeks old at the 
first immunization, a 2nd immunization was given 4 to 10 
weeks later. The graphs indicate the titers for the'3 weeks 
following the primary inoculation and the titer at the time 
of the 2nd inoculation (Figures 4 and 5). Again, an immediate 
rise in titer to the 2nd immunization was demonstrated. 
Figure 3: A graph illustrating the comparative primary and secondary 
responses of CF and CD foals following administration of 
killed Brucella abortus 519 . These foals were injected at 
one week of age and again at 12 weeks. 
! = 2nd injection . 
t = first injection . 
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Figure 4: A graph illustrating the comparative primary and secondary 
responses of CF and CD foals following administration of 
k illed Brucella abortus 519. These foals were injected at 
2 weeks of age, and a 2nd dose was given 4 to 10 weeks later. 
+ = first injection, != 2nd injection. 
5120 QColostrum Deprived (3 Foals) 
o Colostrum Fed (3 Foals) 
2560 
1280 
640 
H 
320 A Q) +' 
/ ' •ri 
"" 1'/ 'o » 160 'Cl 
0 I Cl\ ,.0 
•ri I 0 +' 80 
I:: I <ll 
I 
40 I 
I 
I 
20 I 
I 
10 1 
1 3 4 5 1 2 3 4 5. 6. 
Weeks 
Figure 5: A graph illustrating the comparative primary and secondary 
responses of CF and CD foals following administration of 
killed Brucella abortus Sl9. These foals were injected at 
4 weeks of age, and a 2nd dose was given 4 to 8 weeks later. 
I f =first injection, ~=2nd injection. 
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Figure 6 : A graph illustrating the comparative primary and secondary 
responses of CF and CD foals following administration of 
killed Brucella abortus Sl9 . These foals were injected at 
8 weeks of age and again at 12 weeks . 
! = 2nd injection. 
f = first injection, 
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abortus 519 . These foal s were injected at 12 weeks of age . 
t = injection . 
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Table 7 
Some Comparative Responses. of CF and CD Foals to Killed 
Brucella abortus Sl9 
Foal age Peak response Titer at 2nd Peak response 
(weeks) to first immun. immun. to 2nd immun. 
l CF (3) a 320b 40 3225 
CD (3) 403 50 5120 
2 CF (3) 320 127 2031 
CD (3) 1016 50 2560 
4 CF (5) 1280 184 4457 
CD (2) 453 113 2560 
8 CF (1) 2560 320 2560 
CD (2) 1280 320 1280 
12 CF (6) 3225 
CD (2) 2560 
a Indicates foals' status, i.e., colostrum-fed (CF) or 
colostrum-deprived (CD) and the number of foals in each 
group. See also Table 8. · 
b Titers 
group. 
expressed as the reciprocal of the average for the 
See also Table 8. 
Table 8 
Some Comparative Responses of CD and CF Foals 
to Tetanus Toxoid 
Foal age Peak response Titer at 2nd Peak response 
(weeks) to first immun. immun. to 2nd immun. 
l & 2 CF (5) a 845b 320 13512 
CD (5) 381 160 11763 
4 CF (2) 226 113 14482 
CD (3) 1016 453 25803 
8 CF (3) 320 320 5120 
CD (3) 508 508 8127 
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Foals inoculated at 8 weeks of age with Brucella were 
reinoculated 4 weeks later. Although a rapid titer was noted 
following the 2nd injection, the levels attained were lower 
relative to the primary responses than those seen in previous 
groups (Figure 6). 
Foals immunized at 12 weeks of age did not receive a 
2nd immunization (Figure 7). 
In all age groups evaluated, there were no appreciable 
differences between foals receiving colostrum and colostrum-
deprived foals with regard to either primary or secondary 
antibody responses to Brucella abortus Strain 19 (Table 7). 
Graphs of the comparative results using tetanus toxoid 
are shown in Figures 8-10. Results from one and 2-week-old 
foals in each of the 2 groups compared were combined for data 
presentation purposes (Figure 8). No antibody was detected 
at one week post-inoculation, but measurable levels were noted 
at the 2nd week. Titers to tetanus toxoid increased over a 
longer period post-inoculation than those seen previously to 
killed Brucella abortus. Peak titers were not reached until 
about 5 weeks after.primary immunization of one, 2, and 4 
week-old foals. The decline in anti-tetanus antibody levels 
after peak titers were reached was more gradual in these 
groups than was the decrease in anti-Brucella levels seen 
previously. 
In the one and 2-week-old foal groups, the responses to 
a primary immunization were similar (Table 8). A 2nd 
Figure 8 : A graph illustrating the comparative primary and secondar y 
responses of CF and CD foals following administration of 
tetanus toxoid . These foals were injected at one or 2 weeks 
of age and again at 12 weeks. f = first injection , ! = 2nd 
injection . 
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Figure 9 : A graph illustrating the comparative primary and secondary 
responses of CF and CD foals following administration of 
tetanus toxoid. These foals were injected at 4 weeks of 
age~ and a 2nd dose was given at 12 week s . + = first 
injection, ! = 2nd injection . 
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Figure 10: A graph illustrating the comparative primary and secondary 
responses of CF and CD foals following administration of 
tetanus toxoid. These foals were injected at 8 weeks of 
age, and a 2nd dose was given at 12 weeks. f = first 
injection, ! = 2nd injection. 
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immunization at 12 weeks of age resulted in a rapid response 
in both groups with approximately equal peak titers one to 
2 weeks after the inoculation (Figure 8). 
In 4-week-old foals there was a noticeable difference 
between the groups (Table 8). The colostrum-deprived group 
reached higher peak antibody levels after primary immunization 
than did the colostrum-fed group. Responses to a 2nd 
immunization were again rapid and more equal than the 
primary responses. Peak titers were noted at one week post-
inoculation in the colostrum-fed group and at 2 weeks post-
' inoculation in the colostrum-deprived group (Figure 9). 
Primary responses were similar in 8-week-old foals 
(Table 5). Titers were still increasing in both groups when 
a 2nd immunization was given 4 weeks later. similar rapid 
secondary responses were observed in both groups with peak 
titers at one week post-inoculation followed by a decline in 
anti-tetanus levels (Figure 10). 
Responses of one and 2-week-old foals to human serum 
albumin in colostrum-deprived and colostrum-fed groups were 
combined for data presentation purposes (Figure 11) as was 
done with the previous antigen. Another comparison was made 
of responses of foals given an inoculation of HSA at 4 weeks 
of age (Figure 12). No antibody was detected at one week 
post-immunization, but by 14 days after immunization, anti-
HSA antibody had appeared. Titers increased to peak ·levels 
seen 4 weekq after immunization and then slowly declined. 
Figure 11: A graph illustrating the comparative primary and secondary 
r esponses of CF and CD foals following administration of 
HSA. These foals were injected at one or 2 weeks of age 
and again at 12 weeks. t = first injection , ~ = 2nd injection . 
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responses of CF and CD foals following administration of 
HSA . These foa l s were injected at 4 weeks of age , and a 
2nd dose was given 4 to 8 weeks later . 
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Table 9 
Some Comparative Responses of CD and CF Foals to HSA 
Foals age Peak response Titer at 2nd Peak response 
(weeks) to first immun. immun. to 2nd immun. 
1&2 CF (5) a 160b 70 1522 
CD (6) 69 22 1810 
4 CF (4) 80 40 1280 
CD (2) 80 67 538 
a Indicates foals' status, i.e., colostrum-fed (CF) or 
colostrum-deprived (CD) and the number of foals in each 
group. See also Table lo: 
b Titers 
group. 
expressed as the reciprocal of the average for the 
See also Table 10. 
Table 10 
Some Comparative Responses of CD and CF Foals to 
Killed WEE and EEE Virus 
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Responses to primary immunizations in one and 2-week-old 
foals were similar in both CD and CF groups (Table 9). After. 
a 2nd inoculation given at 12 weeks of age, a rapid secondary 
response was noted with the highest titers recorded 2 weeks 
later followed by decreased levels (Figure 11). 
Four-week-old foals showed similar responses to the 
first HSA inoculation (Table 9). A 2nd immunization was 
given 4 to 8 weeks later. The graph indicates the titers 
for 4 weeks following the first immunization and the titer at 
the time of the 2nd immunization (Figure 12). Again, a rapid 
rise in titer occurred with the secondary response in both 
groups. Peak levels were found at the 2nd week post-
inoculation in the colostrum-deprived group while the titers 
at 3 weeks after immunization in the colostrum-fed group were 
increased over 2nd week levels. 
Measureable antibody to killed Western and Eastern equine 
encephalomyelitis virus was usually produced by the first 
post-inoculation week especially with WEE virus: the production 
of detectable antibody to EEE virus at this time was extremely 
variable (Figures 13-18). A period of several weeks after the 
first inoculation was usually required to attain peak titers. 
A 2nd inoculation produced a rapid secondary response with 
peak titers noted one or 2 weeks later. 
The primary responses of foals immunized at one or 2 
weeks of age with killed WEE virus (Figure 13) or killed EEE 
virus (Figure 14) were quite similar. Secondary responses 
Figure 13: A graph illustrating the comparative primary and secondary 
responses of CF and CD foals following administration of 
killed WEE virus. These foals were injected at one or 2 
weeks of age and again at 12 weeks . + = first injection , 
! = 2nd injection . 
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Figure 14: A graph illustrating the comparative primary and secondary 
responses of CF and CD foals following administration of 
killed EEE virus . These foals were injected at one or 2 
weeks of age and again at 12 weeks . 
! = 2nd injection . 
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Figure 15: A graph illustrating the comparative primary and secondary 
responses of CF and CD foals following administration of 
killed WEE virus. These foals were injected at 4 weeks of 
age, and a 2nd dose was given at 12 weeks. 
injection, i= 2nd injection. 
t = first 
10240 
5120 
.2560 
1280 
... 640 
Q) 
+' 
•.-i 
E-< 320 
» 
'l:l 
0 
.0 160 
•.-i 
+' = 
!''.r <!l 80 
' 40 
20 
10 
OColostrum Deprived:(2'Foals) 
o Colostrum Fed.- (3 Foals) 
;:r--<f 
/ 
--<r--0 
1 3 5 6 7 8 9 
Weeks 
,o--. 
/ 
10 11 13 14 15 16 
Figure 16: A graph illustrating the comparative primary and secondary 
r esponses of CF and CD foa l s fo l lowing administration of 
killed EEE virus . These foals were injected at 4 weeks of 
age, and a 2nd dose was given at 12 weeks . f = first 
injection , ! = 2nd injection . 
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Figure 17: A graph illustrating the comparative primary and secondary 
responses of CF and CD foals following administration of 
WEE virus . These foals were injected at 8 weeks of age , 
and a 2nd dose was given at 12 weeks . 
~=2nd injection . 
+ = first injection, 
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Figure 18: A graph illustrating the comparative primary and secondary 
responses of CF and CD foals following administration of 
killed EEE virus . These foals were injected at 8 weeks of 
age, and a 2nd dose was given at 12 weeks . 
! = 2nd injection. 
+ = first injection, 
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to a 2nd dose given at 12 weeks of age were also quite 
comparable for CD-and CF foals (Table 10). 
The primary response of 4-week-old foals to killed WEE 
virus reached peak levels more rapidly in the CD group 
(Figure 15), but such a difference was not noted with killed 
EEE virus (Figure 16). The secondary response of both groups 
to a 2nd inoculation at 12 weeks was again similar with killed 
WEE virus (Table 10), and, although there seemed to be a 
greater response in colostrum-fed foals to killed EEE virus, 
the size of the group (2 foals) may have accounted for the 
difference. 
Eight-week-old foals showed similar primary responses 
and also secondary responses 4 weeks later to a 2nd injection 
of killed WEE virus (Figure 17) and EEE virus (Figure 18). 
Effect of age 
To evaluate the effect of age on the humeral antibody 
response, foals were grouped according to their age at the· 
time of· the first immunization with a particular antigen. Each 
age group was composed of colostrum-deprived foals and foals 
seronegative to the specific antigen used from birth until 
their first immunization. 
Antibody titers after inoculation with killed Brucella 
abortus Sl9 reached their highest levels at the 2nd week 
post-inoculation in the one, 2, 4, (Figure 19) and 8-week-old 
groups. The highest recorded titer in the 10 and 12-week-old 
Figure 19: A graph illustrating the primary and secondary responses of 
anti- Brucella abortus seronegative foals (CD and CF) to 
killed Brucella abortus 819 . The first dose was administered 
at one , 2 or 4 weeks of age , and a 2nd was given at 12 weeks . 
+ = first injection, ! = 2nd injection . 
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Figure 20: A graph illustrating the primary and secondary responses of 
anti-Brucella abortus seronegative foals (CD and CF) to 
killed Brucella abortus 819 . The first dose was administered 
at 8 , 10, or 12 weeks of age , and a 2nd inoculation was 
given 4 weeks after the first . f = first injection , ! = 2nd 
injection. 
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Table 11 
Some Comparative Responses of Various Foal Age Groups 
to Killed Brucella abortus Sl9 
Foal age Peak response Titer at 2nd Peak response 
(weeks) to first immun. immun. to 2nd immun. 
1 (6) a 320b 45 4561 
2 (6) 570 80 256,0 
4 (7) 861 144 3804 
8 (3) 1280 320 1613 
10 (5) 2560 279 2941 
12 (9) 2792 538 1280 
a Nwnber of foals in each group. See. also Table 12. 
b Titers 
group. 
expressed as the reciprocal of the average for the 
See also Table 12. 
Table 12 
Some Comparative Responses of Various Foal Age Groups 
to Tetanus Toxoid 
Foal age Peak response . .Titer at 2nd Peak response 
(weeks) to first immun. immun. to 2nd immun. 
1 (5) a_ 485b 190 13512 -··- -
2 (5) 640 211 11763 
4 (5) 557 279 13512 
8 (7) 390 390 6451 
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foals' primary responses occurred at one week post-inoculation 
(Figure 20). With increasing age, there was an increase in 
the amount of antibody produced during the primary response 
(Table 11). 
A 2nd immunization produced a rapid increase in 
circulating anti-Brucella antibody with peak titers in 
this secondary response occurring one week later. Generally,-
the secondary responses were similar in all foal groups, but 
the ratio of the secondary response peak titer to that of 
the preceding primary response decreased with increasing 
levels of antibody present at the time of second immunization 
(Table 11). 
The response to tetanus toxoid was compared among 4 foal 
age groups. As noted previously, anti-tetanus antibody was 
not detectable at one week after primary immunization but had --
appeared by 2 weeks post-inoculation (Figure 21). A period 
of 4 to 5 weeks was required before.peak levels of antibody 
were produced. There appeared to be an increase in level of 
antibody present by 2 weeks post-inoculation with increasing_~_ 
foal age. Peak titers reached following primary stimulation, 
however, were similar for all age groups (Table 12). The 
peak of this response in the 8-week-old group could not be 
determined because a 2nd immunization was given while the 
titer was still rising. 
~-
/ 
When a 2nd dose of tetanus toxoid was given, a rapid 
response was observed with production of high levels .of 
Figure 21: A graph illustrating the primary and secondary responses of 
anti-tetanus seronegative foals (CD and CF) to tetanus 
toxoid. The first dose was administered at one , 2, 4, or 
8 weeks of age, and a 2nd was given at 12 weeks . + = first 
injection , ! = 2nd injection. 
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antitetanus antibody (Figure 21), and the responses of all 
the groups were nearly identical. 
Responses to human serum albumin were compared in one, 
2, 4, 8, and 10-week-old foal groups. One week after the 
first inoculation, no antibody could be detected in the one, 
2, or 4-week-old groups (Figure 22). Low levels were 
detected in the 8-week-old foals and higher levels were found 
in the 10-week-old group (Figure 23). Peak titers were 
observed 4 weeks after the first inoculation and then started 
to decline in the one, 2, and 4-week-old foals. It could not 
be determined if peak titers were reached in the 8 and 10 
week-old groups before a 2nd HSA dose was given. Increasing 
age did not appear to influence the eventual peak anti-HSA 
titer (Table 13), but it did shorten the time required for 
the appearance of detectable anti-HSA antibody after 
inoculation. 
The response to a 2nd inoculation was rapid with peak 
antibody levels attained usually at the 2nd week after 
inoculation. Some differences were noted among groups in the 
height of secondary response and were apparently related to 
the degree of primary response, i.e., the greater the 'priinary' 
response the greater the secondary response. 
The response to killed Western and Eastern equine 
encephalomyelitis virus was compared among 4 foal groups 
(Figures 24 and 25). A period of 3 or more weeks was r~quired 
to reach peak titers after inoculation with both antigens. 
Figure 22: A graph illustrating the primary and secondary responses 
of anti-HSA seronegative foals (CD and CF) to human 
ser um albumin . The first dose was administered at one , 
2 , or 4 weeks of age , and a 2nd inoculation was given 
4 to 11 weeks after the first . + = first injection, 
! = 2nd injec tion. 
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Figure 23: A graph illustrating the primary and secondary responses of 
anti- HSA seronegative foals (CD and CF) to human serum 
albumin. The first dose was administered at 8 or 10 weeks 
of age, and a 2nd inoculation was given 4 weeks after the 
first . f = first injection, ! = 2nd injection. 
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Figure 24: A graph illustrating the primary and secondary responses of 
anti- WEE seronegative foals (CD and CF) to killed Western 
equine encephalomyelitis virus. The first dose was 
administered at one , 2 , 4 , or 8 weeks of age, and a 2nd 
inoculation was given at 12 weeks . f =first injection , 
! = 2nd injection . 
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Figure 25: A graph illustrating the pr i mary and secondary responses of 
anti-EEE seronegative foals (CD and CF) to killed Eastern 
equine encephalomyelitis virus. The first dose was 
administered at one , 2, 4 , or 8 weeks of age , and a 2nd 
inoculation was given at 12 weeks . + = first injection, 
! = 2nd injection. 
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Table 13 
some comparative Responses of Various Foal 
Age Groups to HSA 
Foal age Peak response Titer at 2nd Peak response 
{weeks) to first immun. immun. to 2nd immun. 
1 (6)a 1:37-b so 2281 
2 (5) 69 26 1470 
4 (6) 71 57 718 
8 (3) 64 64 403 
10 (S) 211 183 1940 
a 
Number of foals in each group. 
b Titers expressed as the reciprocal of the average for each 
group. 
Table 14 
Some Comparative Responses of Various Foal 
Age-Groups to Killed WEE and EEE Virus 
Foal age Peak response Titer at 2nd Peak response 
(weeks) to first immun. immun. to 2nd immun. 
WEE EEE WEE EEE WEE EEE 
1 (5) a 48b 14 25 7 2940 160 
2 (S) 28 24 28 10 2560 368 
4 (S) 40 9 24 7 2941 160 
8 (4) 34 5 28 5 452 80 
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Peak titers reached following the first injection were 
similar· for all age groups (Table 14). 
Response to a 2nd inoculation produced a rapid secondary 
response with peak titers reached one or 2 weeks later. These 
responses were alike in all groups except those given their 
first dose at 8 weeks of age. In this latter case the response, 
especially to WEE, was less than that observed in the other 
groups (Table 14). 
Effect of maternal antibody 
To evaluate the effect of the presence of maternal 
antibody on the humoral antibody response, .foals were grouped 
according to their titers of a particular antibody at 72 hours 
of age. The foals received their first inoculation at a 
selected age for each antigen. A 2nd dose was given 4 weeks 
after the first. 
Foals were divided into 3 groups on the basis of their 
titers against Brucella abortus at 72 hours of age (Figure 26). 
One group had no detectable antibody at this time and remained 
n~gative until immunization at·l-0 weeks of age. A 2nd··group-
had low levels at 72 hours of age. The average titer of this 
group was, 1:353 
1
and had decreased to nondetectable levels 
at the first immunization. The 3rd group had high maternal 
anti-Brucella levels (1:2100) at 72 hours of age, and they had 
declined to very low levels ( .C.1:10) at 10 weeks of age when 
the first immunization was given. 
Figure 26: A graph illustrating the comparative responses of 10-week-
old foals to killed Brucella abortus Sl9 at 10 and 14 weeks 
of age. Shown are foals with no (Group A), low levels 
(Group B) and high levels (Group C) of maternal anti-
Brucella antibody at 72 hours of age. f = first injection, 
! = 2nd injection . 
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The foals with no detectable anti-Brucella antibody from 
birth until the first inoculation gave an immediate primary 
response to an average peak titer of 1:2560 at one week after 
immunization. Antibody levels declined thereafter to an 
average level of 1:320 when a 2nd inoculation was given 4 weeks 
after the first. Titers increased to an average of 1:2940 
at one week post-immunization. This was only slightly higher 
than the peak titer during the primary response. Levels had 
declined again at the 2nd post-inoculation sampling. 
When given the first inoculation with killed Brucella 
abortus, the foals with low anti-Brucella maternal levels 
responded more slowly than the previous group. Peak titers 
were not noted until the 3rd post-inoculation sampling at 
which time they averaged 1:707. When a 2nd dose was given, 
a good secondary response was noted with a peak response of 
1:4200 reached one week post-inoculation. This was consider-
ably greater than the primary response peak titer. 
The foals with high anti-Brucella abortus maternal levels 
at 72 hours of age responded more slowly and with less anti-
body production than the 2 previous groups to an inoculation 
with killed Brucella abortus. At one week post-inoculation 
there was only a very slight rise in average titer (from 1:4 
to 1:8). The peak response ·(1:262) was noted at the 3rd week 
post-inoculation. A 2nd dose given 4 weeks after the first 
resulted in a strong, rapid secondary response with an average 
peak titer of 1:6241 occurring at one week post-inoculation. 
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The foals were divided into.5 groups based on their. 
anti-tetanus titer at 72 hours of age--no detectable 
circulating antibody, low levels, moderate levels, high 
levels, and very high levels (Figure 27). All foals were 
given their first immunization at 8 weeks of age and a 2nd 
dose 4 weeks later. 
The first foal group, which had no detectable circulating 
anti-tetanus antibody at 72 hours of age, remained negative 
until the 2nd week post-inoculation at which time the 
levels were 1:285. Titers had increased to 1:453 at 12 
weeks of age when the 2nd immunization was administered. 
This resulted in another rapid increase in titer which 
peaked at 14 weeks at 1:7241. 
The foal group with low maternal anti-tetanus levels 
at 72 hours of age (1:40) had nondetectable levels by 7 
weeks~ Response to the first immunization was not noted 
until the 2nd post-inoculation week when the levels had 
risen to 1:10. At the time of the 2nd immunization, the 
titer was 1:226. There was a rapid, strong response with 
titers peaking at 1:20480 at one week after this 2nd 
inoculation. 
The anti-tetanus levels had decreased to 1:26 at 8 weeks 
of age in the 3rd group which had moderate antibody levels 
at'72 hours of age (1:485). Levels continued to decline for 
the 2 weeks after the first immunization to a titer of 1:14. 
Titers rose to 1:75 by the time a 2nd dose was given and 
Figure 27 : A graph illustrating the comparative responses of 8- week- old 
foals to tetanus toxoid at 8 and 12 weeks of age . Shown are 
foals with no (Group A), low levels (Gr oup B), moderate 
levels (Group C), high levels (Group D) and very high levels 
(Group E) of maternal anti - tetanus antibody at 72 hours of 
age . + = fi r st injection , ! 3 2nd injection . 
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then increased again to a peak of 1:3880 at the first 
week after this inoculation. 
The 4th foal group had high anti-tetanus levels at 
72 hours of age (1:5120). By 8 weeks of age the titer had 
decreased to 1:363. No detectable response to the first 
immunization was noted in.this group, and levels continued 
to decline to 1:117 at 12 weeks of age. A 2nd dose 
produced a rise in antibody titers to 1:1451 one week post-
inoculation. 
The last group had very high levels of anti-tetanus 
antibody at 72 hours of age (1:54047). At the time of the 
first immunization, the titer had decreased to 1:2940, and at 
the 2nd immunization they had decreased further to 1:735. 
A slight response to the 2nd immunization was noted with 
antibody levels rising to 1:1174 by the 2nd week post-
inoculation. 
Three groups were compared based on their circulating 
anti-human serum albumin levels at 72 hours of age (Figure 
28). One group had no detectable anti-BSA antibody from 
72 hours until the first inoculation. The 2nd group had 
low levels at 72 hours of age (1:184) while the 3rd group 
had high levels (1:1437). All foals received a first 
immunization at 10 weeks of age, and a 2nd dose was given 
4 weeks later. 
The first group of foals had a rise in anti-BSA titer 
to 1:23 at one week post-inoculation. The titer continued 
Figure 28 : A graph illustrating the comparative responses of 10-week-
old foals to human serum albumin at 10 and 14 weeks of age. 
Shown are foals with no (Group A), low levels (Group B) 
and high levels (Group C) of maternal anti- HSA antibody 
at 72 hours of age . +=first injection , ~=2nd injection . 
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to rise and by the time of the 2nd inoculation it was 1:172. 
The 2nd dose produced a rapid rise in titer with a peak 
response of 1:2032 one week later after which titers again 
decreased. 
Foals with low titers at 72 hours of age had an average 
anti-HSA titer of 1:13 at 10 weeks. The titer was. the same 
at one week post-inoculation and rose to 1:20 at the 2nd week. 
By 14 weeks of age, the titer had increased to 1:160. A 2nd 
dose resulted in a rise in titer that peaked at 1:557 one 
week post-inoculation and then declined. 
The 3rd group had a titer of 1:100 when the first HSA 
immunization was given. The titer declined to 1:30 at 2 
weeks post-immunization and then rose again to 1:80 by the 
4th post-inoculation week. The 2nd dose resulted in another 
rise in titer that peaked at 1:1140 by the 2nd week after 
inoculation. 
Three groups of foals divided according to their titers 
against Western equine encephalomyelitis virus at 72 hours 
of age were compared with regard to their responses to 
killed WEE virus at 8 and 12 weeks of age (Figure 29). The 
first group had no detectable antibody at this time and 
remained negative until immunization at 8 weeks of age. The 
2nd group had low titers (1':836) at this age, while the 3rd 
group had high titers (1:13,278). 
The first group produced a peak primary response of 
1:34 at 3 weeks post-inoculation. A 2nd dose, 4 weeks 
Figure 29: A graph illustrating the comparative responses of 8-week-old 
foals to killed Western equine encephalomyelitis virus at 8 
and 12 weeks of age. Shown are foals with no (Group A), low 
levels (Group B) and high levels (Group C) of maternal anti-
WEE antibody at 72 hours of age. + = first injection, 
! = 2nd injection. 
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after the first, produced a rapid secondary response which 
peaked one week later at 1:342. 
Titers in the 2nd group had decreased to an average of 
1:33 at the time of the first immunization. One week later 
the titer had increased to 1:45 but then decreased again to 
1.: 33 at the 2nd immunization. The 2nd dose produced a 
secondary response which peaked at 1:726 2 weeks later. 
The 3rd group had an average titer of 1:450 at the first 
inoculation, and the titer continued to decrease subsequently 
to 1:92 at the 2nd inoculation. The 2nd dose produced a peak 
response of 1:369 one week later. 
Comparisons were made in 3 groups of foals with regard 
to their anti-Eastern equine encephalomyelitis virus titers 
at 72 hours of age (Figure 30). Foals were immunized with 
killed EEE virus at 8 and 12 weeks of age. Groups compared 
had undetectable levels, low levels (1!63) and high levels/ 
(1: 200) - of maternal anti-EEE antibody at 72 hours of age. ' 
The group with no antibody at 72 hours of age produced 
a peak response of 1:8 at 3 weeks post-inoculation.- The 2nd 
dose resulted in a response of 1:80 one week later. 
Titers in the 2nd group ha~ decreased to 1:16 at 8 weeks 
of age and continued to decrease to 1:11 at 12 weeks of age. 
A secondary response of 1:160 was noted one week after the 
2nd dose. 
The group with high levels of antibody at 72 hours of 
age had a titer of 1:28 at the first immunization, and this 
Figure 30: A graph illustrating the comparative responses of 8-week-old 
foals to killed Eastern equine encephalomyelitis virus at 
8 and 12 weeks of age. Shown are foals with no (Group A), 
low levels (Group B) and high levels (Group C) of maternal 
anti-EEE antibody at 72 hours of age. 
! = 2nd injection. 
f = first injection, 
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subsequently decreased to 1:12 at the 2nd inununization. The 
2nd dose produced an increase in the anti-EEE titer to 1:34 
2 weeks later. 
Persistence of Maternal Antibody 
The disappearance of maternal antibody from the circu-
lation of the foals was calculated from the groups of animals 
used previously in the study on the effect of passive anti-
body on inunune responsiveness. The rate of elimination was 
determined from the antibody titers, relative to foal age. 
The initial titer used (Week O) in all calculations was that 
present in the foal at 72 hours of age. The number of weeks 
used for this measurement varied among the antigens used, but 
at least 6 points were used for each calculation. Comparisons 
were made among groups of foals with different initial (72 
hour) antibody concentrations to each antigen. A pooled 
group average determination was then made for each antibody 
type. Comparisons using pooled group determinations were 
also made among the 5 different antibodies to study their 
relative rates of disappearance. 
The reciprocals of the titers were converted to the 
corresponding logarithm and used to calculate a regression 
equation and regression line for each group (135). The 
regression coefficients were used to calculate antibody half-
life for each group of titers evaluated (116). 
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Maternal antibody half-life (T~) calculations for anti-
Brucella abortus antibody indicated that the antibody was 
catabolized at a constant rate regardless of initial 
concentration (Figure 31). With maternal anti-tetanus anti-
body, however, there was a decrease in half-life time with 
an increase in initial antibody concentration (Figure 32). 
This same relationship was noted with maternal antibody to 
HSA (Figure 33) and WEE virus (Figure 34) but not to EEE 
virus (Figure 35). 
A comparison of pooled groups of each antibody type 
showed a variability in disappearance rates among the 
different antibodies (Figure 36). When regression lines 
were drawn from a single reference titer (1:640) to further 
compare the elimination rates, the differences between 
antibody types was clearly noted (Figure 37). Maternal 
antibody to Brucella abortus Sl9 with a half-life of 7.6 
days was eliminated the most rapidly. Anti-WEE and anti-
tetanus antibody appeared to decrease at a similar rate with 
half-lives of 10.8 and 12.0 days respectively which was 
noteably slower than that for anti-Brucella antibody. Yet 
slower disappearance times were recorded for antibody to 
EEE (T~=l8.2 days) and to HSA (T~=l8.7 days). 
Figure 31: A graph illustrating the elimination of maternal anti-Brucella 
abortus antibody from the circulation of colostrum-fed neonatal 
foals. Shown are foals with low (Group A) and high (Group B) 
levels of antibody at 72 hours of age and a combination of the 
2 groups (pooled) . T~=antibody half-life in days . 
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Figure 32: A graph illustrating the elimination of maternal anti-tetanus 
antibody from the circulation of colostrum- fed neonatal f oals . 
Shown are foals with low (Group A), moderate (Group B) , high 
(Group C) and very high (Group D) levels of antibody at 72 
hours of age and a combination of the 4 groups (pooled). 
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Figure 33: A graph illustrating the elimination of maternal anti-HSA 
antibody from the circulation of colostrum- fed neonatal 
foals. Shown are foals with low (Group A) and high 
(Group B) levels of antibody at 72 hours of age and a 
combination of the 2 groups (pooled). T~antibody half-
life in days . 
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Figure 34: A graph illustrating the elimination of maternal anti-Western 
equine encephalomyelitis virus antibody from the circulation 
of colostrum-fed neonatal foals. Shown are foals with low 
(Group A) and high (Group B) levels of antibody at 72 hours 
of age and a combination of the 2 groups (pooled) . 
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Figure 35: A graph illustrating the elimination of maternal anti-Eastern 
equine encephalomyelitis virus antibody from the circulation 
of colostrum-fed neonatal foals. Shown are foals with low 
(Group A) and high (Group B) levels of antibody at 72 hours 
of age and a combination of the 2 groups (pooled). 
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Figur e 36 : A g r aph illustrating a comparison of previous pooled antibody 
e l imination rates for maternal antibody to Brucella abortus , 
tetanus toxoid , human serum albumin and Western and Eastern 
equine encephalomyelitis virus in neonatal c olostrum- fed 
foals . T~antibody half- life in days . 
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Figure 37: A graph illustrating a comparison of elimination rates for 
maternal antibody to Brucella abortus , tetanus toxoid , 
human serum albumin and Western and Eastern equine 
encephalomyelitis virus in neonatal colostrum- fed foals 
utilizing a single initial reference titer of 1:640 . 
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DISCUSSION 
No detectable serum antibody was found in the pre-· 
nursing sera of any foal by the serological techniques used •. 
This was true even though the circulating antibody titers 
in the dams to some of the antigens were 1:20480. Some 
foals had prenursing titers of 1:20 to WEE virus and 1:40 
to EEE virus, but these titers were considered to be non-
specific and a function of the hemagglutination-inhibition 
test. The lack of detectable serum antibody at birth 
confirms similar reports of others (1, 22, 81). 
By 24 hours of age substantial antibody had appeared 
in the foals' sera due to intestinal absorption of maternal 
antibody present in the ingested colostrum. Serum titers 
in the foals at this time closely approximated that of their 
dams: this was especially true of antibody to tetanus 
toxoid and WEE and EEE virus, while foal titers to Brucella 
abortus Sl9 and HSA were lower than their dams'. The 
presence of two groups of comparative titers may have been 
related to quantitative differencds in .the amount of anti-
body present in the dam's colostrum and/or to differences 
in the immunoglobulin types(s) composing the colostral 
antibody to each antigen and the foal's ability to absorb 
these different immunoglobulins. The newborn calf non-
selectively absorbs all immunoglobulin types (15, 99), while 
the pig shows the ability to absorb all immunoglobulin 
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classes although some may be absorbed more readily than 
others (28, 100). The newborn foal appears to have an 
enhanced absorption of IgG as compared to other equine 
immunoglobulin classes, i.e., IgG(T), IgM, IgA, and AI (76). 
The antibody present in the colostrum, therefore, to tetanus 
toxoid and WEE and EEE virus may have been predominantly IgG 
in nature, while colostral antibody to Brucella abortus and 
HSA may have contained a higher proportion of the other 
immunoglobulin classes. It is of interest to note that 
the tetanus toxoid and killed WEE and EEE virus used as 
antigens were incorporated into aluminum hydroxide, while 
the other 2 antigens were not. 
At 72 hours of age the foals' serum titers had either 
remained equivalent to the 24-hour-old titers or had risen 
slightly. ~y 24 hours of age the foal had acquired almost 
all of its circulating maternal antibody, and only a slight 
amount was absorbed subsequent to that. This is in agreement 
with the findings of Jeffcott (57, 60) and Bruner et al. (21). 
A comparison of mare titers- at parturition and foal titers 
at 72 hours with a larger number of animals demonstrated 
results similar to those seen at 24 hours, i.e., nearly 
equivalent titers of anti-tetanus and anti-WEE and anti-
EEE virus antibody and somewhat lower foal titers of anti-
HSA and especially anti-Brucella abortus antibody. 
Foals deprived of colostrum and fed a milk replacer 
product for the first 72 hours of life did not acquire any 
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detectable circulating antibody when allowed to nurse their 
dams after this period. After 72 hours of age, therefore, 
only nondetectable amounts of colostral antibody, if any, 
were absorbed by the neonatal foals. 
Decline in foal maternal antibody levels from 72 hours 
of age showed some variability among the different antibody 
types as well as among the different initial concentrations 
of a particular antibody. This was to be expected given 
a heterogeneity of immunoglobulin classes representative 
of antibody. 
The most rapid decrease was noted with maternal anti-
Brucella abortus agglutinating antibody which had a half-
life of 7.5 to 7.6 days. This was most likely due to a 
high proportion of IgM composing this antibody. Brucella 
as a primary antigen induces the formation of IgM antibody 
followed by some IgG antibody, but in some species even 
hyperimmunization fails to produce very much IgG antibody (11). 
The half-time of survival of IgM is one-tenth to one-half 
that of IgG in man, rabbits, guinea pigs, and mice (153), 
one-fourth to one-fifth that of IgG in pigs (28, 100) and 
ohe-fifth that of IgG in calves (99). 
The similarity of the half-life values for the groups 
with initial low and high levels of anti-Brucella abortus 
antibody also reflected the probable high percentage of 
IgM antibody. The catabolic rate of IgG is in direct 
proportion to the plasma concentration (153), but the 
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catabolic rate of IgM is independent of the serum concentration 
(153 , 8) . An increase or decrease in IgM serum concentration 
does not l ead to a concomitant change in the speed of 
catabolism. 
Antibody to tetanus toxoid and Western e quine encephalo-
myeli tis virus showed similar average half-life values , 
12 . 0 vs 10 . 8 days . This may have indicated that the 
proportion of immunoglobulin types present in these two 
antibody populations were very simi lar . A point strengthening 
s uch a conclusion is that both a ntigens were incorporated 
in the same adjuvant , aluminum hydroxide , and administered 
together . Antibody to Eastern equine enceph a lomyelitis virus 
did not yield an equivalent half-life value , but this was 
considered to be associated with the serological procedure 
used to detect the antibody. Nonspecific titers of 1:10 
and 1:20 were common and tended to increase the average titers 
especially at the l atter points along the regression line . 
This decreased the slope of the line and increased half-life 
values , so it is not certain that the calculated values are 
a true representation of the half- life of t h is antibody . 
The half- life val ue for antibody to human serum albumin 
(18 . 7 days) exhibited a slower catabolic rate than for the 
others discussed above . Again this probabl y reflected a 
heterogeneity of the immunoglobulin classes composing this 
antibody which were in apparently different proportion than 
in previous antibody populations . No effort was made to 
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calculate the relative amounts of IgGa' IgGiJ, IgGc, IgM, 
IgG(T), IgA, or aggregating immunoglobulin (AI) composing 
these antibodies. There are large differences in the relative 
catabolic rates of the different immunoglobulins in most 
species (153). Differences among IgG subclasses also exi·st 
in man (IgG3 is catabolized more rapidly than IgG1 , IgG2
, or 
IgG4 ) (132) and mice (131). 
As the maternal antibody titers to tetanus toxoid 
increased, the antibody half-life decreased (16.l days for 
the lowest to 10.1 days for the highest titer) indicating 
an elevation in the antibody catabolic rate with increased· 
levels. Similar results were obtained with antibody to 
WEE virus and HSA. Two plaµsible explanations can be 
offered to account for this phenomenon, and both may play 
some major or minor role. 
It is known in man that the catabolic rate of IgG. is 
directly proportional to the serum concentration of IgG (153). 
An increase, therefore, in IgG levels leads to increased IgG 
catabolism and subsequently a shorter half-life. This same 
situation exists in mice (34) and rabbits (153). It should 
be noted that such a relationship does not exist for IgM and 
IgA in man (153). A similar situation may be inferred for 
the horse with IgG and possible with IgG(T) and AI. 
Increased levels of these immunoglobulins could result in 
their being more rapidly catabolized. 
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Another possibility is that as maternal antibody l e v e ls 
increase1 so do the proportions of various immunoglobulin 
class constituents. An increased p ercentage of a more 
rapid l y metabolized imrnunoglobulin class would1 therefore , 
l ead to a s horter h a lf-life for that a n tibody . Hyperimmun-
ization of horses with t etanus or diphtheria toxoid results 
in a l arge r e l ative increase in the production of IgG (T) 
typ e antibodies (15 1 1 152 ) 1 s o this represents a possible 
cause of anti-tetanus a ntibody catabolic rate changes if 
IgG(T) half-life is shorter than that for IgG. 
When compared to other half-life determinations for the 
young foal (6 1 , 102) 1 the values presented here are notab ly 
lower. The only similar hal f- life value s are those of 20 
days for Clostridium we l chii type A antitoxin and 18 days 
for gamma globulin in foals with greater than average l evels 
(61) and 18 . 7 days for anti-RSA antibody in this study. In 
fact , the value s calculated in t his study, especially with 
antibody t o tetanus toxoid a nd WEE virus , more n e arly ref l e cted 
those found in t h e adult horse , i.e. , 11 . 0 days for gamma 
globulin (82) and 14.3 days for IgG (92). I t should be 
noted t hat t he c a lculat ions p resented h e r e not on l y 
include the effects of catabolism but a lso antibody dilution 
due to inc r easing animal size a nd1 subse que ntly1 i ncreas ing 
size of intra a nd e xtra-vascular compartments . The 
estimation s 1 t h e refore 1 of Reilly and MacDougall (102) of a 
151 
half-life of 23±4.5 days of IgG in the neonatal foal may be 
more accurate since corrections were made for increases in 
body weight. 
The primary response to Brucella abortus s.19 observed in 
these neonatal foals exhibited a distinctly different pattern 
than the responses to the other antigens. This difference 
was probably due to the fact that tetanus toxoid, WEE and 
EEE virus, and HSA were all administered in an adjuvanted 
form while Brucella abortus was not. Some difference .. ,was 
likely due, also, to the differences in antigenicity among 
the agents used. 
Primary responses to antigenic stimulation are usually 
characterized by a lag period of variable length during 
which there is no detectable serum antibody followed by the 
appearance of antibody of the IgM class (147). Particulate 
antigens lead to a more rapid onset of antibody production 
than soluble antigens partly because they are more rapidly 
cleared from the circulation and presented to the immune 
system (49). ·Secondary or anamnestic responses are 
characterized by the almost immediate production of high 
levels of predominantly IgG antibody, although some antigens 
may stimulate considerable IgM antibody (65). 
Certain roles for macrophages, T lymphocytes and B 
lymphocytes in antibody response have been described (13, 45,· 
150). The macrophage may bind antigen to its surface and 
interact with a T lymphocyte (thymus-dependent lymphocyte, 
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"antigen-reactive" cell) having a specific receptor for that 
antig.en. · The T lymphocyte presents the antigen to a B lympho-· 
cyte (bursa equivalent-derived lymphocyte, "antigen-sensitive" 
cell) and also stimulates the B cell to undergo proliferation 
and differentiation that leads to the production of antibody 
and immunologic memory. "Processing" of the antigen may 
occur during the time it is in contact with the macrophage 
and T lymphocyte. Some antigens (thymus-independent) do not 
require T lymphocyte involvement, and many of these are also 
macrophage independent. 
The primary response to Brucella abortus was character-
ized by a rapid increase in agglutinating antibody production 
during the first one to 2 weeks post-inoculation followed by 
a decline in levels. Brucella abortus Sl9 has been shown to 
produce a greater predominance of IgM antibodies during the 
primary response than other antigens, at least in some species 
(109), and may be the case in this study. 
Antigens which induce primarily IgM antibody production 
are, ·for the most part, thymm;-independent (45). They are 
large polymeric molecules with a high density of repeating 
identical determinants and are not easily metabolized by the 
body. The lack of a need for T lymphocyte and macrophage 
cooperation may lead to a more rapid appearance of antibody 
to these antigens than to thymus-dependent antigens since 
less steps would be required to activate B lymphocytes. The 
absence of T lymphocyte cooperation also prevents a shift to 
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predominantly IgG antibody production, possibly because T 
lymphocyte activity may be needed to turn on IgG precursor 
cells to switch from IgM to IgG production (45). 
When a second inoculation of killed Brucella abortus was 
given, there was a rapid production of antibody with peak 
levels noted by one week post-inoculation suggesting a 
typical secondary response. Although variability was noted 
at times among the levels of primary responses, secondary 
responses were usually similar indicating an equal state of 
recall preparation in each group. There was a tendency for 
the secondary responses to be lowered with increasing levels 
of antibody from the primary response present at inoculation. 
This indicated some antibody suppression of the immune 
response which will be discussed in more detail later. 
In contrast to the response to Brucella, the primary 
responses to tetanus toxoid and HSA showed a more delayed 
onset, a slower increase in levels to more of a plateau than 
a peak and a subsequent slower decrease in titer. This pattern 
probably reflects both the nature of the antigens (soluble 
proteins) and their combination with an adjuvant, i.e., the 
use of aluminum hydroxide in the preparation of tetanus 
toxoid and bentonite with the HSA. The slower primary 
response to a soluble protein was noted when nonadjuvanted 
tetanus toxoid was administered to sheep (107). The first 
detectable antibody appeared at 9 days post-inoculation, and 
peak titers were exhibited 12 to 18 days post-inoculation. 
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with adjuvants typically more time is required for antibody 
formation, and antibody levels increase more slowly (49). 
Several mechanisms have been proposed to explain the 
effects of an adjuvant on the immune response (2, 30, 36, 
37, 156) including: 1) a protracted antigenic stimulus 
resulting from the slow release of antigen, 2) denaturation 
or precipitation (in the case of soluble proteins) of the 
antigen, 3) stimulation of macrophages to more effectively 
process the antigen, 4) the recruitment of reactive cells 
by a "trapping" mechanism whereby macrophages and T and B 
lymphocytes are brought together in increased numbers in 
lymphoid tissue draining a site of adjuvant inoculation, 
5) stimulation of the proliferation of T lymphocytes and 
6) stimulation of the proliferation and differentiation of 
B lymphocytes. 
Different adjuvants may work by one or more of the above 
mechanisms. Aluminum hydroxide may cause the slow release of 
antigen from a depot at the site of injection. A smaller 
amount of antigen would, therefore, be available initially 
and only after a sufficient quantity of antigen contacted 
the involved immune system cells, would antibody become 
detectable. This mechanism may be involved in the late onset 
of detectable antibody production and slow rise of serum titer. 
Aluminum hydroxide also causes the precipitation of tetanus 
toxoid thus changing its structural nature to a more 
immunogenic one. 
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Bentonite absorbs soluble proteins onto its particulate 
structure (158} and may, therefore, change the structural 
nature of a soluble protein such as HSA. Bentonite is 
phagocytized by macrophages (156) and may affect their ability 
to present antigen to T lymphocytes or to process antigen. 
Bentonite also causes "trapping" or sequestration of 
circulating lymphoid cells in lymphoid tissue as do several 
other adjuvants (37). Trapping refers to a shutting-off of 
the outflow of lymphocytes from lymphoid tissue~ it brings 
macrophages and T and B lymphocytes into closer· contact in· 
larger numbers. It is interesting to note that particulate 
antigens also cause.trapping, while soluble proteins do not, 
which may explain some of the difference in the pattern of 
primary response to each. 
The stimulation of T and/or B 1:1'.Illphocytes may be due to 
some specific action of an adjuvant on the particular cell 
population involved (30). Some adjuvants affect only T 
lymphocytes, others.affect only B lymphocytes, and some 
involve both. The effect of aluminum hydroxide and bentonite 
in this regard is unknown. 
The primary response to killed EEE and WEE virus was 
detectable at one week post-inoculation but exhibited the 
same characteristics of the other responses to adjuvanted 
materials. The particulate nature of the viral antigen 
induced an earlier formation of antibody than would be seen 
1·56 
with soluble proteins, but the adjuvanted nature created 
a more prolonged response. 
The prolonged stimulation of the immune response by an 
adjuvanted product would necessarily lead to features of a 
secondary response incorporated into the primary response, 
i.e., the shift in production of antibody to predominantly 
an IgG type. Thus, additional exposures to the adjuvanted 
immunogen would create an almost exclusive IgG type response 
leading to. an increasingly greater predominance of this 
serum antibody. The slower decline in these antibody titers 
after peak levels were reached as compared to those to 
Brucella abortus may reflect a greater proportion of IgG in 
this antibody which is catabolized more slowly. 
Responses to a 2nd inoculation (secondary response) 
were rapid and peak titers were attained in one to 2 weeks. 
Immune memory had been well-established, and only small 
amounts of antigen were required to trigger subsequent anti-
body production. There is some indication that antigen-anti-
body complexes may also initiate the 'trapping mechanism (37) 
which, combined with immunologic memory, would lead to a rapid, 
strong secondary response. 
Hyperimmunization of the horse with toxoids, e.g., tetanus 
or diphtheria toxoid, leads to the production of large 
proportions of specific IgG(T) antibody (151, 152). Although 
not studied in this work, a similar response probably occurred 
·to some extent in the foals immunized with tetanus toxoid. 
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The shift to IgG(T) production and memory during the response 
to the first irrununization with the adjuvanted tetanus toxoid 
probably contributed significa ntly to t he ability of a 2nd 
inoculation to produce a rapid , strong response. 
The age of the foal at t he time of administration of 
antigen had a demonstrable effect upon the primary response 
to some of the a ntigens used . The effect noted varied some-
what between antige ns, but it was apparent that the ageing 
process played a similar role for the various responses to the 
antigens . 
Some apparent maturation of the humeral antibody response 
occurred with increasing foal age . Such maturation l ed to 
the production of increasing levels of antibody during the 
primary response to Brucella abortus and shortened the post-
inoculation interval required for p eak antibody production. 
This activity occurred within the first 2 weeks following 
irrununization . In this same r esponse period the effect of 
maturation on antibody production to tetanus toxoid and 
human serum albumin was also noted , i . e ., the shortening 
of the interval betw~en inoculation and detectable antibody 
production . After this initial period there was an apparent 
"leveling" of response to stimulation ; the maturation 
process during these first 2 weeks appeared to have progressed 
to a similar extent in all age groups . No differences in 
peak titers or the time required to attain them, therefore , 
could be discerned . 
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The effects of increasing age to raise peak titers to 
killed Brucella abortus and to shorten the time required to 
produce detectable antibody to tetanus toxoid and human serum 
albumin were similar in that their influence was noted 
primarily in the first 2 weeks subsequent to inoculation. 
This 'may suggest a similar underlying mechanism(s) operating 
on 2 fundamentally different types of antigen. 
Several possibilities exist to explain the phenomena 
that ageing produces: 1) an increase in the number of cells 
capable of responding to antigen, 2) an increase in the 
ability to process antigen or 3) an increase in the ability 
to produce IgG. one, a combination, or all of these mechanisms 
may play a role. 
An increase in the population of "antigen-sensitive" 
cells (B lymphocytes, bursa equivalent-derived lymphocytes) 
after birth has been advocated by some (78, 143) as the cause 
of an increase in antibody-forming potential during the first 
months of postnatal life. The mechanism responsible for the 
increase could be an adaptive one, i.e., repeated contacts 
with antigens (bacterial antigens, antigens from food), 
especially via the gut tract. These antigens have a variety 
of dete:rminants, some which may invoke antibodies that cross-
react with other antigens (143). Evidence for such a develop-
ment has been acquired by raising pigs delivered by hysterec-
tomy in a germ~free environment with a low-antigenic diet 
and subsequently exposing them to antigens (143). In such 
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pigs, the ability to produce antibody does not change 
quantitatively during the first 60 days after birth, while 
pigs raised under conventional conditions have a considerable 
increase in immunologic capacity during the first month. 
Arguments against such a theory have been raised (126, 
149) based on work in the fetal lamb and fetal monkey •. In 
these animals the fetus gives a very competent adult-type 
response on the first introduction of some antigens which 
could indicate that an adult level of "antigen-sensitive" 
cells were already present (109). There appears to be-a-0 ·---" ·-
hierarchy of development of responses to antigens during 
fetal development with some strong antigens stimulating 
antibody production at various stages of fetal development, 
while weak antigens may not induce any antibody response, 
even for some time after birth (136). 
Such a mechanism may be operational in the foal. It 
was noted during the experimentation that many mares carried 
low titers (1:20 to 1:40) of antibody that agglutinated 
Brucella abortus Sl9 cells, although they had no history of 
exposure to this agent. Similar findings in the horse have 
been reported by others (39, 80), and the antibody involved 
has been considered to be a nonspecific, cross-reacting type. 
Contact with agents that stimulate the production of this 
antibody could conceiveably enlarge the number of "antigen-_ 
sensitive" cells to Brucella abortus in the developing foal. 
By a similar mechanism an increased number of "antigen-
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sensitive" cells to tetanus toxoid or human serum albumin 
would allow the earlier production of detectable levels of 
antibody during the primary response. 
The possible increase in the ability to process antigen 
for antibody production during neonatal life suggests a change 
in the abilities of macrophages and/or T lymphocytes (thymus-
dependent lymphocytes). Both of these cells appear to play 
an important role in humoral antibody responses (13) 
especially to thymus-dependent antigens such as soluble 
proteins. 
Evidence of differences in macrophage function and 
morphology between very young and adult animals has been 
presented for several animal species (3, 130) and has been 
suggested as a possible source of delayed responsiveness to 
sheep red blood cells in newborn mice (4). Development of T 
lymphocyte function after birth has also been suggested as 
an event in postnatal immunologic maturation of mice (9). 
Gradual development of one or both of these cell types in 
neonatal foals may lead to an age-related increase in the 
ability to produce antibody. 
The young animal's earliest antibodies formed under 
controlled antigenic stimulation have been found to be of 
an IgM type in most species (101). In .the neonatal foal 
the IgM class has been shown to be the first whose levels 
increase due to autogenous production (76, 111). As 
development proceeds, the ability to produce IgG becomes 
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increasingly apparent . The addition of this second irnmuno-
globulin class to antibody production would lead to increased 
antibody producing capabilities with ageing . 
The delayed onset of IgG synthesis may by closely 
related to the first proposed mechanism, i.e ., an increase 
in "antige n-sensitive" cells with ageing . A late maturation 
of IgG- producing cells would add to the population involved; 
evidence exists that the switch to increased IgG synthesis 
is an ontogenic development (95) . 
Although there was some age-related difference in the 
foal' s ability to produce antibody during a primary response, 
considerable immunologic capacity existed from the earliest 
inoculation age , one week . Many of the r eports dealing 
with other species presented previously in the review of 
lite rature have demonstrated a lack of similar ability in 
these animals at an equival ent age . The fact that the foal 
is born at a more advanced stage of physiological development 
than many other animals may be r esponsible to a large degree 
for the noted difference in immune capabi l ities (130) . 
The neonatal foal is , therefore, fully capable of 
responding to antigens similar to the ones used in thi s 
study from one week of age , providing no inhibiting infl uences 
such as passive serum antibody were present . No particular 
advantage would be gained by waiting until a n o l der age to 
begin a foalhood vaccination program and , indeed, would l eave 
the foa l unprotected until such measures were taken . 
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Colostrum deprivation had generally little effect on the 
immune response to the antigens employed. colostrum-deprived 
foals at one and 2 weeks of age had slightly greater primary 
responses to killed Brucella abortus Sl9, tetanus toxoid, and 
killed WEE and EEE virus than did CF foals, although this was 
not true of the response to human serum albumin. Four-week-
old, colostrum-deprived foals also responded better to 
tetanus toxoid than did colostrum-fed foals. Responses to 
other antigens at 4 weeks of age and to all antigens in the 
other older groups exhibited no ·notable differences between 
colostrum-fed and colostrum-deprived groups. 
A deficiency in humeral antibody responsiveness has 
been noted in neonatal, colostrum-deprived pigs (53, 119, 
120). This same effect was not observed in neonatal calves 
(106, 128) and was not noted in this study. 
The lack of responsive ability in the CD neonatal pigs 
was attributed to a lack of a factor normally supplied in the 
colostrum which participated in antibody production, i.e., 
small amounts of specific antibody (119). The reported 
requirement for the specific antibody was based upon Jerne's 
natural selection hypothesis of antibody formation (62, 63) 
which postulates that preformed antibody is needed for anti-
body formation. Mechanistically, antibody would interact 
with antigen aiding in the transport of antigen to antibody-
forming cells. 
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comparisons between this study and those with CD pigs 
(119, 120) are difficult. The CD pigs were obtained by 
hysterotomy, raised in a sterile environment and fed· a diet 
of known composition. The CD foals in this stu~y were born 
normally, raised in a normal environment and fed a diet of 
unknown composition. Such differences could easily introduce 
factors to the foals which would cause them to respond in 
a manner unlike that which might be seen if they were 
handled similar to the CD pigs. 
The equine and porcine species have similar placental 
structures, i.e., they are both epitheliochorial in nature 
(14). It has been reported that some transplacental 
transmission of antibody may occur in pigs before birth (91), 
although this has not been conclusively determined. Such a 
situation could exist in the equine, especially since in 
several reports (61, 69, 117) some slight precolostral 
transmission of antitoxins· was observed. If this is the 
case, small amounts of specific preformed antibody would 
already be present at birth, and colostrum would not be needed 
to supply them. The serological techniques used in this 
study did not demonstrate the presence of any detectable 
specific antibody before nursing nor at any subsequent 
pre-immunization time in CD foals and so cannot confirm such 
reports. It is possible, however, that specific preformed 
antibody was present in the foals below the level of 
detection by the procedures used. 
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There appeared to be a slightly greater responsive 
ability in the colostrum-deprived foals. This could have 
been due to a general inunune system stimulation provided 
in the first week of life by the presence of clinical 
illness which was noted in all CD foals. Such a stimulation 
could act upon lymphoid tissue, especially cell types such 
as the macrophage, T lymphocyte, and/or B lymphocyte to 
hasten their maturation, especially at a young age. 
Colostrum-deprived foals did appear to have normal capacity 
to produce humeral antibody responses to a variety of 
antigens from as early as one week of age. 
The failure of foals to receive colostrum led to 
severe problems with infectious diseases during the first 
week of age, especially with Escherichia coli septicemias. 
Similar problems have been seen in CD animals o~ other 
species (38, 55). Even with high levels of broad-spectrum 
antibiotics the foals exhibited signs of clinical illness 
(elevated body temperature, depression, anorexia) during 
the first few days of life. None of these problems were 
noted in colostrum-fed foals, and they required no anti-
microbial therapy. The effects of the deprivation of 
colostrum gave dramatic evidence of the importance of 
colostrum as regards maintenance of good health and 
survivability in the young foal. 
The presence of maternal antibody had a demonstrable 
effect on the primary inunune response to all the antigens 
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used. Generally, the more maternal antibody present at the 
time of the first inoculation, the slower and weaker was the 
ensuing response. 
The response to killed Brucella abortus demonstrated 
just that effect. While a peak response in seronegative, 
10-week-old foals was noted at one week post-inoculation, 
the presence of maternal antibody delayed the noted peak 
response until the 3rd post-inoculation week. The presence 
of increasing amounts of maternal anti-Brucella antibody in 
the foals at the time of injection resulted in lower peak 
titers during the primary response. 
The response to tetanus toxoid exhibited a lack of 
active antibody production following the primary immunization 
in 2 groups with high levels of maternal antibody present; 
titers continued to decrease in a linear fashion after 
inoculation. Some sensitization had apparently occurred, 
however, because a 2nd injection resulted in an increased 
titer one week later in both groups. (Primary responses to 
tetanus were not detectable until the 2nd week post-inocula-
tion.) There was a suppression of the secondary response 
in these groups because they had noteably lower peak titers 
following a 2nd injection than did groups with lower maternal 
antibody levels. This was especially true of the group with 
the highest maternal antibody levels; a 2nd dose produced only 
a slight increase in titer. Maternal antibody, therefore, 
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demonstrated its capacity to inhibit a primary response and 
also a secondary response as previously reported '(148). 
Primary responses to human serum albumin and killed WEE 
and EEE virus all showed the same general effect. No apparent 
influence was noted on· secondary responses except in the 
·group with the highest levels of maternal anti-EEE anti-
body in which some decreased production was observed. 
The ability of passive antibody to affect the primary 
and secondary response to its respective antigen i's of. 
considerable interest in the study of the normal regulatory 
mechanisms that limit the extent of these responses. Such 
mechanisms restrict the amount of antibody formed to an 
antigenic stimulus preventing the body from uncontrolled 
synthesis of unnecessary and potentially harmful levels, 
especially to nonmetabolizable antigens. 
The post-inoculation suppression of measurable antibody 
formation in a primary response by the presence of pre-
existing antibody has been observed to be highly specific 
for such diverse antigens as H-2 isoantigens in mice (BS), 
sheep and chicken red blood cells (157) and picrylated bovine 
'f-globulin (12). only maternal antibody to Brucella abortus 
would, therefore, affect the response to this antigen. Such 
specificity implies .that interaction of passive antibody with 
the antigen is the first step in suppression since the only 
mechanism known at present by which an antibody molecule can 
recognize antigenic specificity is by combining with specific 
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antigen (144). An alternate mechanism suggests that 
specifically competent lymphoid cells have antigen-like 
structures on their surface, and that antibody interaction 
with such receptors can inhibit active antibody production 
(113). Such receptors have not been demonstrated. 
Not all antigenic sites on a molecule have to be bound 
by antibody for suppression to occur (148). Less than half 
of the antigenic sites on a single molecule of diphtheria 
toxoid can be bound to· antitoxin and cause suppression of 
the antibody response (145). Some inhibition of the 
primary response was noted in the face of low and even 
undetectable levels of antibody to Brucella abortus, tetanus 
toxoid and HSA, although probably only enough antibody to 
cover some fraction of the antigenic determinants was 
present. 
The ability of passive antibody to interfere with 
sensitization or a secondary response is less effective 
than with a primary response (90, 112, 146), although it 
has been demonstrated (86, 87, 145). It is probable that 
less antigen.is required for sensitization or priming for a 
secondary response than is required for an active primary 
response. Similarly, less antigen is required to elicit a 
secondary response. The effect of high levels of maternal 
anti-tetanus antibody, therefore; to preven't an observable 
primary response but not completely block sensitization may 
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have been due to a slight amount of antigen yet available 
for stimulation of immunocompetent cells. 
The smaller dosage requirement for a detectable 
secondary response and the difficulty in inhibiting it are 
probably related to the increase in the average binding 
affinity that occurs after immunization as demonstrated by 
Eisen and Siskind (31). Such a change likely reflects 
similar changes in the cell population producing the anti-
body. These cells have specific cellular receptors which 
are considered to be antibody ( "ce_ll associated" antibody) 
identical to that they produce, and so, as there is a 
heterogeneity of serum antibody, s~ch also exists for the 
antibody-forming cells (127, 148). It is theorized that 
antigen interacts with its ·_complementary "cell associated" 
antibody during some step in the process of antibody 
formation. With a limite~ amount of antigen or a decreasing 
amount of antigen after immunization, only cells having "cell 
associated" antibody of the highest binding affinity can 
capture antigen and be stimulated (148). With increased 
receptor avidity the immune mechanlsm becomes less suppress-
ible by serum antibody (unless it is of greater avidity). 
The anti-tetanus levels that were able to block a primary 
response were thus unable to completely block a se.condary 
response, although they severely restricted it. 
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The combining of passive antibody to antigen may be able 
to block an immune response by rendering the antigenic 
determinants sterically unavailable to immune system cells 
(148). Alternatively, the combination may affect antigen 
metabolism, and the antigen may be more rapidly broken 
down and eliminated, or it may be removed from the circula-
tion at a site that precludes significant antibody formation 
(148). 
It is interesting that passive antibody produced a 
delayed but demonstrable primary response to the antigens 
studied here. The delay may have been due to the eventual 
availability of more antigen to the immune system to 
stimulate such an event. Some dissociation of antigen from 
antigen-antibody complexes in vivo has been demonstrated 
using diphtheria toxoid in rabbits and guinea pigs (145). 
This freeing of antigen from antibody may be a simple 
"disattachment", especially with antibody of low avidity, 
or may be due to metabolism of some of the antibody. Such 
"free" antigen then becomes available to the appropriate 
cells to initiate an antibody response, albeit weaker. due 
to a less than optimal amount of antigen. 
The site in the body of antigen-antibody interaction 
in suppression of the antibody response is yet unknown. 
One possible site is in the circulation, but this is not 
necessary because antibody given subsequent to the clearing 
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of antigen from the circulation is still effective in 
blocking a response (148). Inhibiting activity may, therefore, 
occur· after the. antigen has contacted immune system cells. 
Evidence has accumulated that suggests that there are at 
least 2 antigen-dependent steps in the progression of 
events from initial cell contact with antigen to production 
of antibody (16, 24). The first step may involve contact 
with an ''antigen-reactive cell" which may be a macrophage 
or T lymphocyte. The 2nd contact may be with an "antigen-
sensitive" cell which is a B lymphocyte and which has "cell 
associated" antibody on its surface. The first step may 
involve antigen processing and the production and/or release 
of an activator complexed with the antigen (16). This 
complex could then be introduced to the appropriate "antigen-
sensitive" cell where the antigen attaches to the "cell'-
associated" antibody and the activator stimulates the cell 
to eventually produce antibody or to proliferate leading to 
production of memory cells and more antibody-forming cells. 
Memory cells would also require a subsequent antigen inter-
action to be transformed into antibody-producing cells. 
Lower quantities of antigen induce primarily memory cells 
and few antibody-forming cells, i.e., sensitization (16). 
The fact tb.at sensitization occurred with tetanus toxoid 
indicates that at least the first and probably, to some 
extent, the 2nd antigen-dependent step had taken place with 
some memory cell production the primary result. 
171 
The relationship of maternal antibody to the active 
immune response also has much practical application. The 
effectiveness of an immunization in a young animal depends· 
largely on the amount of passive antibody present at the 
time of injection and the ability of the antibody to suppress 
the immune response. 
The level of maternal antibody acquired by the newborn 
is related closely to the serum titer of its dam at parturi-
tion as has been discussed previously. The antibody levels 
in the dam are a reflection of her past disease and immuni-
zation history, especially that during the period of time 
the foal was residing in utero. Such history is, therefore, 
very important in estimating the amount of antibody that 
the newborn foal would receive subsequent to nursing and 
antibody absorption. The half-life values calculated 
previously may be used to estimate an age at which the anti-
body levels should be low enough so they interfere only 
minimally with active immunization. Some antibody may be 
present and inhibit to some extent a primary response and, yet 
a 2nd immunization will produce a'normal anamnestic response. 
A more desirable method of determining antibody levels 
in the foal would be to measure serum antibody levels in the 
dam at parturition or in the foal at 72 hours of age. From 
this information calculations using the antibody half-life 
values would give an estimate of passive titers at various 
l 
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ages. From the data on the effect of various titers on the 
responses to different antigens presented in this report, 
one should be able to determine quite accurately an 
immunization age for each antigen. Such a system called 
a nomograph has been devised for use in pup immunization 
against canine distemper virus (41). The relatively high 
value of many newborn foals would make this a feasible and 
-
valuable tool to the veterinary practitioner and horseowner. 
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SUMMARY 
The ability of the neonatal foal to pro~uce humeral 
antibody was studied in relation to the effects of colostrum-
deprivation, age at immunization and the presence or absence 
of maternal antibody at immunization. Also investigated 
were the transfer of maternal antibody to the newborn 
foal and its subsequent rate of elimination. 
Pregnant Shetland pony and Quarter Horse mares were 
immunized at various stages of gestation with tetanus toxoid-
killed Western and Eastern equine encephalomyelitis virus in 
aluminum hydroxide or killed Brucella abortus Sl9 and human 
serum albumin in bentonite. Colostrum-fed foals and foals 
deprived of colostrum for 72 hours after birth were inoculat.ed 
with these same antigens at one, 2, 4, 8, 10, or 12 weeks 
of age and a 2nd immunization was given 4 to 11 weeks later. 
Blood samples were collected before nursing, at 24 and 72 
hours and one week of age and weekly thereafter for 15-17 
weeks. 
Colostrum-deprived and colostrum-fed foals responded 
with equal abiiity to the antigens studied. There was some 
enhancement of the primary response to the antigens used as 
age increased, but secondary responses were similar, and the 
foals were able to respond well to the antigens employed 
from as early as one week of age. Depending on the particular 
levels at the time of immunization, maternal antibody 
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exhibited an ability to suppress or block a primary response, 
inhibit sensitization and depress the secondary response. 
Maternal antibody was not present in detec.table levels 
in the foal before nursing. After nursing the serum levels 
increased rapidly to approximate those of the dam at 24 and 
72 hours of age, although there was some variation in the 
comparative serum levels between antibody types. A hetero~ 
geneity of elimination rates of the various antibodies was 
noted, and with some antibodies an increase in catabolism 
was noted as initial levels increased. Average half-life 
values of specific antibodies were! 1) B. abortus = 7, 6 days,· 
2) tetanus toxoid = 12.0 days, 3) WEE = 10.8 days, and 4) 
BSA= 18.7 days. 
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